American Realty Capital Healthcare Trust 10-Q 31 Oct 14 2014 Q3 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	9 Months Ended
	Sep. 30, 2014	Oct. 31, 2014
Document and Entity Information [Abstract]	'	'
Entity Registrant Name	'AMERICAN REALTY CAPITAL HEALTHCARE TRUST INC	'
Entity Central Index Key	'0001499875	'
Current Fiscal Year End Date	'--12-31	'
Entity Filer Category	'Non-accelerated Filer	'
Document Type	'10-Q	'
Document Period End Date	30-Sep-14	'
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q3	'
Amendment Flag	'false	'
Entity Common Stock, Shares Outstanding	'	169,316,247

CONSOLIDATED_BALANCE_SHEETS

CONSOLIDATED BALANCE SHEETS (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Real estate investments, at cost:	'	'
Land	$149,964	$107,719
Buildings, fixtures and improvements	1,826,348	1,363,858
Construction in progress	19,673	11,112
Acquired intangible lease assets	240,402	181,264
Total real estate investments, at cost	2,236,387	1,663,953
Less: accumulated depreciation and amortization	-181,279	-87,350
Total real estate investments, net	2,055,108	1,576,603
Cash and cash equivalents	33,452	103,447
Restricted cash	3,135	1,381
Investment securities, at fair value	1,587	14,670
Preferred equity investment	8,800	0
Prepaid expenses and other assets	27,725	17,431
Deferred costs, net	18,530	21,041
Total assets	2,148,337	1,734,573
LIABILITIES AND EQUITY	'	'
Mortgage notes payable	303,831	259,348
Mortgage premiums, net	3,612	2,769
Credit facility	619,400	0
Below-market lease liabilities, net	4,811	5,543
Derivatives, at fair value	56,633	333
Accounts payable and accrued expenses	33,088	17,460
Deferred rent and other liabilities	5,121	2,949
Dividends payable	0	10,427
Total liabilities	1,026,496	298,829
Preferred stock, $0.01 par value per share, 50,000,000 shares authorized, none issued or outstanding at September 30, 2014 and December 31, 2013	0	0
Common stock, $0.01 par value per share, 300,000,000 authorized, 169,316,247 and 180,463,898 shares issued and outstanding at September 30, 2014 and December 31, 2013, respectively	1,691	1,805
Additional paid-in capital	1,462,165	1,591,941
Accumulated other comprehensive loss	-219	-3,243
Accumulated deficit	-353,553	-158,378
Total stockholders' equity	1,110,084	1,432,125
Non-controlling interests	11,757	3,619
Total equity	1,121,841	1,435,744
Total liabilities and equity	$2,148,337	$1,734,573

CONSOLIDATED_BALANCE_SHEETS_Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)	Sep. 30, 2014	Dec. 31, 2013
Statement of Financial Position [Abstract]	'	'
Preferred stock, par value (in dollars per share)	$0.01	$0.01
Preferred stock, authorized (in shares)	50,000,000	50,000,000
Preferred stock, issued (in shares)	0	0
Preferred stock, outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$0.01	$0.01
Common stock, authorized (in shares)	300,000,000	300,000,000
Common stock, issued (in shares)	169,316,247	180,463,898
Common stock, outstanding (in shares)	169,316,247	180,463,898

CONSOLIDATED_STATEMENTS_OF_OPE

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (USD $)	3 Months Ended		9 Months Ended
In Thousands, except Share data, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Revenues:	'	'	'	'
Rental income	$63,311	$29,285	$166,412	$66,157
Operating expense reimbursements	4,557	2,859	13,008	7,522
Resident services and fee income	5,741	2,003	14,947	3,083
Total revenues	73,609	34,147	194,367	76,762
Operating expenses:	'	'	'	'
Property operating and maintenance	31,315	13,940	81,032	26,576
Operating fees to affiliates	2,711	0	5,063	0
Acquisition and transaction related	10,266	3,107	36,144	7,858
Vesting of Class B units for asset management services	0	0	12,917	0
Fair value of listing note	-1,750	0	56,400	0
General and administrative	3,175	1,429	7,874	2,928
Depreciation and amortization	32,606	17,140	93,262	41,548
Total operating expenses	78,323	35,616	292,692	78,910
Operating loss	-4,714	-1,469	-98,325	-2,148
Other income (expenses):	'	'	'	'
Interest expense	-7,942	-4,350	-20,593	-10,754
Income from preferred equity investment and investment securities and interest income	320	354	1,115	609
Loss on sale of investment securities	-464	0	-129	0
Total other expense	-8,086	-3,996	-19,607	-10,145
Net loss	-12,800	-5,465	-117,932	-12,293
Net loss (income) attributable to non-controlling interests	679	-10	1,487	-46
Net loss attributable to stockholders	-12,121	-5,475	-116,445	-12,339
Other comprehensive income:	'	'	'	'
Designated derivatives, fair value adjustment	107	-77	100	266
Unrealized gain (loss) on investment securities, net	661	-1,879	2,924	-2,864
Comprehensive loss attributable to stockholders	($11,353)	($7,431)	($113,421)	($14,937)
Basic and diluted weighted average shares outstanding (in shares)	169,090,342	178,231,121	175,234,437	142,163,876
Basic and diluted net loss per share attributable to stockholders (usd per share)	($0.07)	($0.03)	($0.66)	($0.09)

CONSOLIDATED_STATEMENTS_OF_CHA

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (USD $)	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit	Total Stockholders' Equity	Non-controlling Interests
In Thousands, except Share data, unless otherwise specified
Balance at Dec. 31, 2012	'	'	'	'	'	'	'
Increase (Decrease) in Stockholders' Equity [Roll Forward]	'	'	'	'	'	'	'
Increase in interest in Reliant Rehabilitation - Dallas, TX and University of Wisconsin Health MOB - Monona, WI	'	'	'	'	'	'	($100)
Balance at Dec. 31, 2013	1,435,744	1,805	1,591,941	-3,243	-158,378	1,432,125	3,619
Balance (in shares) at Dec. 31, 2013	'	180,463,898	'	'	'	'	'
Increase (Decrease) in Stockholders' Equity [Roll Forward]	'	'	'	'	'	'	'
Common stock issued through distribution reinvestment plan (in shares)	'	2,344,631	'	'	'	'	'
Common stock issued through distribution reinvestment plan	22,254	23	22,231	'	'	22,254	'
Common stock repurchases (in shares)	'	-13,718,187	'	'	'	'	'
Common stock repurchases, inclusive of fees and expenses	-152,144	-137	-152,007	'	'	-152,144	'
Dividends declared	-78,730	'	'	'	-78,730	-78,730	'
Contributions from non-controlling interest holders	750	'	'	'	'	'	750
Vesting of Class B units for asset management services	12,917	'	'	'	'	'	12,917
Equity-based compensation (in shares)	'	225,905	'	'	'	'	'
Equity-based compensation	844	'	844	'	'	844	0
Distributions to non-controlling interest holders	-586	'	'	'	'	'	-586
Increase in interest in Reliant Rehabilitation - Dallas, TX and University of Wisconsin Health MOB - Monona, WI	-4,300	'	-844	'	'	-844	-3,456
Other comprehensive income	3,024	'	'	3,024	'	3,024	'
Net loss	-117,932	'	'	'	-116,445	-116,445	-1,487
Balance at Sep. 30, 2014	$1,121,841	$1,691	$1,462,165	($219)	($353,553)	$1,110,084	$11,757
Balance (in shares) at Sep. 30, 2014	'	169,316,247	'	'	'	'	'

CONSOLIDATED_STATEMENTS_OF_CAS

CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013
Cash flows from operating activities:	'	'
Net loss	($117,932)	($12,293)
Adjustment to reconcile net loss to net cash provided by operating activities:	'	'
Depreciation	57,310	27,235
Amortization of intangibles	35,952	14,313
Amortization of deferred financing costs	4,827	2,462
Amortization of mortgage premiums	-1,036	-593
Accretion of below-market lease liabilities and amortization of above-market lease assets, net	287	346
Vesting of Class B units for asset management services	12,917	0
Equity-based compensation	844	46
Fair value of listing note	56,400	0
Loss on sale of investment securities	129	0
Changes in assets and liabilities:	'	'
Prepaid expenses and other assets	-13,819	-7,283
Due from affiliate	0	-4,480
Accounts payable and accrued expenses	15,099	8,097
Deferred rent and other liabilities	2,172	1,393
Net cash provided by operating activities	53,150	29,243
Cash flows from investing activities:	'	'
Investment in real estate and preferred equity investment	-527,411	-702,714
Deposits for real estate	-500	-6,690
Capital expenditures	-2,530	-283
Purchase of investment securities	-3,036	-19,448
Proceeds from sale of investment securities	18,914	0
Net cash used in investing activities	-514,563	-729,135
Cash flows from financing activities:	'	'
Payments of note payable	0	-2,500
Payments of mortgage notes payable	-1,047	-220
Proceeds from credit facility	619,400	0
Payments on credit facility	0	-26,000
Payments of deferred financing costs	-1,998	-16,620
Proceeds from issuance of common stock	0	1,196,900
Proceeds from the issuance of OP units	750	0
Common stock repurchases, inclusive of fees and expenses	-152,144	-1,764
Payments of offering costs and fees related to stock issuances	0	-122,343
Dividends paid	-66,903	-31,124
Payments to non-controlling interest holders	-4,300	0
Distributions to non-controlling interests holders	-586	-278
Restricted cash	-1,754	-1,117
Net cash provided by financing activities	391,418	994,934
Net change in cash	-69,995	295,042
Cash, beginning of period	103,447	13,869
Cash, end of period	33,452	308,911
Supplemental Disclosures:	'	'
Cash paid for interest	16,749	8,840
Cash paid for income taxes	1,590	132
Non-Cash Investing and Financing Activities:	'	'
Mortgage notes payable assumed or used to acquire investments in real estate	45,530	39,192
Premiums on assumed mortgage notes payable	1,879	692
Common stock issued through distribution reinvestment plan	$22,254	$34,319

Organization

Organization	9 Months Ended
	Sep. 30, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
Organization	'
	Organization
	American Realty Capital Healthcare Trust, Inc. (the "Company") invests primarily in real estate serving the healthcare industry in the United States. The Company owns a diversified portfolio of healthcare-related real estate, focusing predominantly on medical office buildings ("MOBs") and seniors housing communities. Additionally, the Company selectively invests across the healthcare continuum in hospitals, post-acute care facilities and other properties. As of September 30, 2014, the Company owned 153 properties and one preferred equity investment located in 31 states and comprised of 7.9 million rentable square feet.
	In February 2011, the Company commenced its initial public offering (the "IPO") on a "reasonable best efforts" basis of up to 150.0 million shares of common stock, $0.01 par value per share, at a price of $10.00 per share, subject to certain volume and other discounts. The Company closed its IPO in April 2013 and operated as a non-traded real estate investment trust ("REIT") through April 6, 2014. On April 7, 2014, the Company listed its common stock on the NASDAQ Global Select Market ("NASDAQ") under the symbol "HCT" (the "Listing"). Concurrent with the Listing, the Company offered to purchase up to 13.6 million shares of its common stock at a price of $11.00 per share (the "Tender Offer"). As a result of the Tender Offer, on May 2, 2014, the Company purchased 13.6 million shares of its common stock at a price of $11.00 per share, for an aggregate of $150.1 million, excluding fees and expenses relating to the Tender Offer and including fractional shares repurchased thereafter.
	The Company, which was incorporated on August 23, 2010, is a Maryland corporation that qualified as a REIT for U.S. federal income tax purposes beginning with the taxable year ended December 31, 2011. Substantially all of the Company's business is conducted through American Realty Capital Healthcare Trust Operating Partnership, L.P., a Delaware limited partnership (the "OP"). The Company has no direct employees. The Company has retained American Realty Capital Healthcare Advisors, LLC (the "Advisor") to manage its affairs on a day-to-day basis. The Company has retained American Realty Capital Healthcare Properties, LLC (the "Property Manager") to serve as the Company's property manager.  Realty Capital Securities, LLC (the "Dealer Manager") served as the dealer manager of the IPO and continues to provide the Company with various services. The Advisor, Property Manager and Dealer Manager are under common control with the parent of the Company's sponsor, American Realty Capital V, LLC (the "Sponsor"), as a result of which, they are related parties and each has received or may receive compensation and fees for services related to the IPO, the Listing, the Merger (described below) and for the investment and management of the Company's assets.

Merger_Agreement

Merger Agreement	9 Months Ended
	Sep. 30, 2014
Business Combinations [Abstract]	'
Merger Agreement	'
	Merger Agreement
	On June 1, 2014, the Company entered into an Agreement and Plan of Merger (the "Merger Agreement") with Ventas, Inc., a Delaware corporation ("Ventas"), Stripe Sub, LLC, a Delaware limited liability company and wholly-owned subsidiary of Ventas ("Merger Sub"), Stripe OP, LP, a Delaware limited partnership of which Merger Sub is the sole general partner ("OP Merger Sub"), and the OP. The Merger Agreement provides for the merger of the Company with and into Merger Sub, with Merger Sub surviving as a wholly-owned subsidiary of Ventas (the "Merger"), and for the merger of OP Merger Sub with and into the OP, with the OP continuing as the surviving partnership (the "Partnership Merger"). The board of directors of the Company has unanimously approved the Merger Agreement, the Merger and the other transactions contemplated by the Merger Agreement, including the Partnership Merger.
	Pursuant to the terms and subject to the conditions set forth in the Merger Agreement, at the effective time of the Merger (the "Effective Time"), each outstanding share of common stock, par value $0.01 per share, of the Company will be converted into the right to receive, pursuant to an election made by each holder of the Company's common stock, (i) $11.33 in cash, limited to 10% of the shares outstanding of the Company's common stock, or (ii) 0.1688 (the "Exchange Ratio") shares of common stock, par value $0.25 per share, of Ventas ("Ventas Common Stock").
	In addition, pursuant to the Partnership Merger, at the Effective Time: (i) the Company's interest as the general partner of the OP will remain outstanding and constitute the only outstanding general partnership interest in the OP; and (ii) each unit of limited partnership interests in the OP (the "OP units") issued and outstanding immediately prior to the Effective Time of the Partnership Merger, including the 5,613,374 OP units to be issued in respect of the termination of the Listing Note Agreement (as defined in Note 10 — Subordinated Listing Distribution Derivative), will be converted into such number of Ventas Class C units (as defined in the limited partnership agreement of the OP as contemplated to be amended and restated by the Merger Agreement) of the OP as is equal to the Exchange Ratio. In addition, unless otherwise notified by Ventas, prior to the Effective Time, the Company has agreed to terminate the Company's Employee and Director Incentive Restricted Share Plan, the Company's 2011 Stock Option Plan and the 2014 Advisor Multi-Year Outperformace Agreement (the "OPP"), all, however, contingent on the occurrence of the Effective Time.
	The completion of the Merger is subject to various customary conditions. The Merger Agreement includes certain termination rights for both the Company and Ventas and provides that, in connection with the termination of the Merger Agreement, under specified circumstances, the Company may be required to pay to Ventas expense reimbursement in an amount equal to $10.0 million. The Merger Agreement also provides for the payment of a termination fee by the Company in the amount of $55.0 million (net of the expense reimbursement, if previously paid) if the Merger Agreement is terminated under specified circumstances. The Merger is expected to close during the fourth quarter of 2014.
	Pursuant to the Merger Agreement, all Merger related fees, other than fees and expenses arising from any litigation, the obtainment of consents, debt prepayment penalties, defeasance costs, breakage costs, indemnification of liabilities (excluding liabilities to the Advisor or American Realty Capital Healthcare Special Limited Partnership, LLC, (the "SLP")) and accounting expenses are capped at $23.6 million. During the three and nine months ended September 30, 2014, the Company has incurred $7.8 million and $13.1 million, respectively, related to the Merger.

Summary_of_Significant_Account

Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2014
Accounting Policies [Abstract]	'
Summary of Significant Accounting Policies	'
	Summary of Significant Accounting Policies
	The accompanying consolidated financial statements of the Company included herein were prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") for interim financial information and with the instructions to this Quarterly Report on Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. The information furnished includes all adjustments and accruals of a normal recurring nature, which, in the opinion of management, are necessary for a fair presentation of results for the interim periods. All intercompany accounts and transactions have been eliminated in consolidation. The results of operations for the three and nine months ended September 30, 2014 are not necessarily indicative of the results for the entire year or any subsequent interim period.
	These consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto as of, and for the year ended December 31, 2013, which are included in the Company's Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission (the "SEC") on February 26, 2014. There have been no significant changes to the Company's significant accounting policies during the nine months ended September 30, 2014, other than the updates described below.
	Reclassifications
	Certain prior quarter amounts have been reclassified to conform to the current quarter presentation.
	Listing Note
	Concurrently with the Listing, the Company caused the OP to issue the Listing Note (see Note 10 — Subordinated Listing Distribution Derivative). Except as provided below, the Listing Note's value will be determined, in part, based on the average market value of the Company's outstanding common stock for the period 180 days to 210 days after the Listing. Until the principal amount of the Listing Note is determined, the Listing Note is treated as a derivative and the Company estimates the contingent consideration using a valuation model and records the fair value of the Listing Note on the consolidated balance sheets. The initial fair value and subsequent changes in fair value are recorded in the consolidated statements of operations and comprehensive loss. Concurrently with the execution of the Merger Agreement, the OP and the SLP entered into an amendment to the Listing Note agreement. Pursuant to the amended Listing Note agreement, contingent upon the occurrence of the Merger at the Effective Time, 5,613,374 OP units will be issued in respect of the termination of the Listing Note.
	Multi-Year Outperformance Agreement
	On April 7, 2014 (the "OPP Effective Date") in connection with the Listing, the Company entered into the OPP with the OP and the Advisor. Because the Advisor can terminate at any time and receive the value of the award at the next anniversary date, the estimated value of the award as of the first anniversary was expensed on the OPP Effective Date and the estimated value of the award on the second and third anniversaries is being amortized over the first year and first two years of the OPP, respectively, and adjusted to reflect the probability of the closing of the Merger. The award and related expense is adjusted each reporting period for changes in the estimated value. Concurrently with the execution of the Merger Agreement, the Company, the OP and the Advisor entered into an agreement terminating the OPP, pursuant to which the OPP will terminate without payment to the Advisor, contingent on the closing of the Merger (see Note 17 — Equity-Based Compensation).
	Tender Offer
	The Company recorded the excess of the cost of the tendered shares over its par value to additional paid-in capital.
	Recently Issued Accounting Pronouncements
	In February 2013, the Financial Accounting Standards Board ("FASB") issued new accounting guidance clarifying the accounting and disclosure requirements for obligations resulting from joint and several liability arrangements for which the total amount under the arrangement is fixed at the reporting date. The new guidance was effective for fiscal years, and interim periods within those fiscal years, beginning on or after December 15, 2013. The adoption of this guidance did not have a material impact on the Company's consolidated financial position, results of operations or cash flows.
	In April 2014, the FASB amended the requirements for reporting discontinued operations. Under the revised guidance, in addition to other disclosure requirements, a disposal of a component of an entity or a group of components of an entity is required to be reported in discontinued operations if the disposal represents a strategic shift that has (or will have) a major effect on an entity's operations and financial results when the component or group of components meets the criteria to be classified as held for sale, disposed of by sale or other than by sale. The Company has adopted the provisions of this guidance effective January 1, 2014, and has applied the provisions prospectively. The adoption of this guidance did not have a material impact on the Company's consolidated financial position, results of operations or cash flows.
	In May 2014, the FASB issued revised guidance relating to revenue recognition. Under the revised guidance, an entity is required to recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The revised guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2016. Early adoption is not permitted under GAAP. The revised guidance allows entities to apply the full retrospective or modified retrospective transition method upon adoption. The Company has not yet selected a transition method and is currently evaluating the impact of the new guidance.

Real_Estate_Investments

Real Estate Investments	9 Months Ended
	Sep. 30, 2014
Real Estate [Abstract]	'
Real Estate Investments	'
	Real Estate Investments
	The following table presents the allocation of the assets acquired and liabilities assumed during the nine months ended September 30, 2014 and 2013:
			Nine Months Ended September 30,
	(Dollar amounts in thousands)		2014			2013
	Real estate investments, at cost:
	Land		$	41,245		$	64,357
	Buildings, fixtures and improvements		461,095			595,820
	Construction in progress		8,561			4,819
	Total tangible assets		510,901			664,996
	Acquired intangibles:
	In-place leases		59,238			78,020
	Above-market lease assets		—			5,371
	Below-market lease liabilities		—			(4,272		)
	Total assets acquired, net		570,139			744,115
	Preferred equity investment (see Note 5 — Preferred Equity Investment)		8,800			—
	Deposits for real estate		(3,590		)	—
	Mortgage notes payable assumed or used to acquire real estate investments		(45,530		)	(39,192		)
	Premiums on mortgages assumed		(1,879		)	(692		)
	Other liabilities assumed		(529		)	(1,517		)
	Cash paid for acquired real estate and preferred equity investments		$	527,411		$	702,714
	Number of properties purchased		38			53
	The allocations to buildings, fixtures and improvements have been provisionally assigned to each class, pending receipt of additional information from a third party specialist.
	The following table presents unaudited pro forma information as if the acquisitions during the nine months ended September 30, 2014, had been consummated on January 1, 2013. Additionally, the unaudited pro forma net loss attributable to stockholders was adjusted to exclude acquisition related expense of $8.2 million from the nine months ended September 30, 2014.
			Nine Months Ended September 30,
	(In thousands)		2014			2013
	Pro forma revenues		$	221,631		$	139,050
	Pro forma net loss attributable to stockholders		$	(107,176	)	$	(7,975	)
	The following table presents future minimum base rental cash payments due to the Company over the next five years and thereafter. These amounts exclude contingent rent payments, as applicable, that may be collected from certain tenants based on provisions related to sales thresholds and increases in annual rent based on exceeding certain economic indexes among other items.
	(In thousands)		Future Minimum
			Base Rent Payments
	October 1, 2014 — December 31, 2014		$	28,642
	2015		116,563
	2016		117,860
	2017		117,183
	2018		112,136
	Thereafter		810,444
			$	1,302,828
	The following table lists the tenants (including for this purpose, all affiliates of such tenants) whose annualized rental income on a straight-line basis represented approximately 10% or greater of total annualized rental income for all portfolio properties on a straight-line basis as of September 30, 2014 and 2013:
			September 30,
	Tenant		2014		2013
	UnitedHealth Group Incorporated		*		10.70%
	____________________________
	*	Tenant's annualized rental income on a straight-line basis was not greater than 10% of total annualized rental income for all tenants as of the period specified.
	The following table lists the states where the Company has concentrations of properties where annualized rental income on a straight-line basis represents approximately 10% or more of consolidated annualized rental income on a straight-line basis for all properties as of September 30, 2014 and 2013:
			September 30,
	State		2014		2013
	Florida		*		11.40%
	Georgia		12.80%		16.60%
	Oregon		*		18.40%
	Texas		11.80%		*
	____________________________
	*	State's annualized rental income on a straight-line basis was not 10% or more of total annualized rental income for all portfolio properties as of the date specified.

Preferred_Equity_Investment

Preferred Equity Investment	9 Months Ended
	Sep. 30, 2014
Preferred Equity Investment [Abstract]	'
Preferred Equity Investment	'
	Preferred Equity Investment
	As of September 30, 2014, the Company owned a preferred equity investment in an entity that owns the 80th Street Residence, a seniors housing community located at 430 East 80th Street in the Upper East Side of Manhattan. As of September 30, 2014, the preferred equity investment had a carrying amount of $8.8 million. The investment has a ten-year term maturing in March 2024, a 0.5% origination fee and a 10.0% current pay rate distributed on a semi-annual basis. As of December 31, 2013, the Company did not have any preferred equity investments.
	The preferred equity investment has a fixed return based on contributed capital and no participation in profits or losses of the real estate activities.  As such, the Company accounts for the returns earned in income from preferred equity investment and investment securities and interest income on the consolidated statements of operations and comprehensive loss.  The Company assesses the investment for impairment on a periodic basis.

Investment_Securities

Investment Securities	9 Months Ended
	Sep. 30, 2014
Investment Securities [Abstract]	'
Investment Securities	'
	Investment Securities
	As of September 30, 2014, the Company had investments in a real estate income fund with an aggregate fair value of $1.6 million. As of December 31, 2013, the Company had investments in common stock, redeemable preferred stock and a senior note with an aggregate fair value of $14.7 million. The real estate income fund is managed by an affiliate of the Sponsor (see Note 15 — Related Party Transactions and Arrangements). These investments are considered available-for-sale securities and, therefore, increases or decreases in the fair value of these investments are recorded in accumulated other comprehensive loss as a component of equity on the consolidated balance sheets unless the securities are considered to be other than temporarily impaired, at which time the losses would be reclassified to expense.
	The following table details the unrealized gains and losses on investment securities as of September 30, 2014 and December 31, 2013:
	(In thousands)	Cost		Gross Unrealized Gains		Gross Unrealized Losses			Fair Value
	30-Sep-14
	Investment securities	$	1,573	$	14	$	—		$	1,587
	31-Dec-13
	Investment securities	$	17,580	$	202	$	(3,112	)	$	14,670
	Unrealized losses as of September 30, 2014 were considered temporary and, therefore, no impairment was recorded during the three and nine months ended September 30, 2014. During the nine months ended September 30, 2014, the Company sold investments in common stock, redeemable preferred stock and a senior note with a cost of $19.0 million for $18.9 million, resulting in a realized net loss on sale of investment securities of $0.1 million.

Credit_Facility

Credit Facility	9 Months Ended
	Sep. 30, 2014
Debt Disclosure [Abstract]	'
Credit Facility	'
	Credit Facility
	On May 25, 2012, the Company entered into a senior revolving credit facility in the aggregate principal amount of $50.0 million (the "Credit Facility") with KeyBank National Association ("KeyBank"). On October 25, 2012, the Company entered into an amendment, which increased the maximum commitments under the Credit Facility to $200.0 million.
	On July 24, 2013, the Company entered into an unsecured amended and restated credit agreement (the "Amended Facility"), which allows for total borrowings of up to $755.0 million, comprised of a $500.0 million term loan component and a $255.0 million revolving loan component. The Amended Facility also contains a subfacility for letters of credit of up to $25.0 million. The Amended Facility contains an "accordion feature" to allow the Company, under certain circumstances, to increase the aggregate term loan borrowings under the Amended Facility to up to $750.0 million and the aggregate revolving loan borrowings to up to $450.0 million, or up to $1.2 billion of total borrowings.
	Pursuant to the Amended Facility, the Company has the option, based upon its corporate leverage, to have the Amended Facility priced at either: (a) LIBOR, plus an applicable margin that ranges from 1.60% to 2.20%; or (b) the Base Rate, plus an applicable margin that ranges from 0.35% to 0.95%. Base Rate is defined in the Amended Facility as the greatest of (i) the fluctuating annual rate of interest announced from time to time by KeyBank as its "prime rate," (ii) 0.5% above the federal funds effective rate or (iii) 1.0% above the applicable one-month LIBOR. Upon such time as the Company receives an investment grade credit rating as determined by major credit rating agencies, the Company will have the option, based upon its credit rating, to have the Amended Facility priced at either: (a) LIBOR, plus an applicable margin that ranges from 0.95% to 1.70%; or (b) the Base Rate, plus an applicable margin that ranges from 0.00% to 0.70%. The Amended Facility includes an unused fee per annum equal to (a) 0.25% of any unused balance of the revolving facility, if such unused balance exceeds 50% of the available revolving facility, (b) 0.15% of any unused balance of the revolving credit facility, if such unused balance is equal to or less than 50% of the available revolving facility and (c) 0.25% of any unused balance of the term facility.
	The Amended Facility provides for monthly interest payments for each Base Rate loan and periodic payments for each LIBOR loan, based upon the applicable LIBOR loan period, with all principal outstanding being due on the maturity date. The term loan component of the Amended Facility matures in July 2018 and the revolving loan component of the Amended Facility matures in July 2016. The revolving loan component of the Amended Facility contains two, one-year extension options. The Amended Facility may be prepaid from time to time and at any time, in whole or in part, without premium or penalty, subject to reimbursement of certain costs and expenses. In the event of a default, the lenders have the right to terminate their obligations under the Amended Facility and to accelerate the payment on any unpaid principal amount of all outstanding loans.
	On January 23, 2014, the Company entered into the first amendment to the Amended Facility (the "First Amendment"), which permits the Company to make a maximum of five borrowings of term loans from the period beginning July 24, 2013 to July 24, 2014 (the "Term Loan Commitment Period") in an aggregate principal amount which decreases over time as follows: for the period beginning July 24, 2013 to January 24, 2014, $500.0 million; for the period beginning January 25, 2014 to April 24, 2014, $400.0 million; and for the period beginning April 25, 2014 to July 24, 2014, $200.0 million. Additionally, under the First Amendment, the Company may from time to time, at its option, increase the total term loan commitment up to an amount not to exceed the sum of $750.0 million plus the amount of the initial term loan commitment not borrowed during the Term Loan Commitment Period.
	On April 7, 2014, the Company entered into the second amendment to the Amended Facility (the "Second Amendment"). The Second Amendment, among other things, (i) permits the issuance of the Listing Note to the SLP following the Listing, (ii) modifies the distribution covenant to account for the suspension of the Company's distribution reinvestment plan (the "DRIP"); (iii) permits the issuance of long term incentive plan units ("LTIP units") to the Advisor and (iv) modifies certain other terms of the Amended Facility to allow the Company to make additional restricted payments, including the Tender Offer.
	As of September 30, 2014, the balance outstanding under the Amended Facility was $619.4 million, with a weighted average interest rate of 1.8%. The Company's unused borrowing capacity was $54.3 million, based on the assets assigned to the Amended Facility as of September 30, 2014. Availability of borrowings is based on a pool of eligible unencumbered real estate assets. There were no advances outstanding as of December 31, 2013.
	The Amended Facility requires the Company to meet certain financial covenants, including the maintenance of certain financial ratios (such as specified debt to equity and debt service coverage ratios) as well as the maintenance of a minimum net worth. As of September 30, 2014, the Company was in compliance with the financial covenants under the Amended Facility.

Note_Payable

Note Payable	9 Months Ended
	Sep. 30, 2014
Debt Disclosure [Abstract]	'
Note Payable	'
	Note Payable
	In September 2011, the Company entered into an unsecured $4.5 million note payable with an unaffiliated third party investor. The note bore interest at a fixed rate of 8.0% per annum and was due to mature in September 2014. The note had two one-year extension options. The note required monthly interest payments with the principal balance due at maturity. The note could be repaid at any time, in whole or in part, without premium or penalty. Notwithstanding the foregoing, after the initial maturity date, the lender had a right to require the repayment in full of any outstanding principal and interest under the note upon 60 days' notice. The note was repaid in full in January 2013 at the Company's election.

Mortgage_Notes_Payable

Mortgage Notes Payable	9 Months Ended
	Sep. 30, 2014
Debt Disclosure [Abstract]	'
Mortgage Notes Payable	'
	Mortgage Notes Payable
	The Company's mortgage notes payable as of September 30, 2014 and December 31, 2013 consist of the following:
					Outstanding Loan Amount as of				Effective Interest Rate
	Portfolio		Encumbered Properties		September 30, 2014		December 31, 2013					Interest Rate	Maturity
					(In thousands)		(In thousands)
	Texarkana ASC - Texarkana, TX		1		$	2,108	$	2,143	5.58	%		Fixed	Jun. 2016
	Carson Tahoe Specialty Medical Center - Carson City, NV (1)		3		21,751		21,751		5.08	%		Fixed	Sep. 2017
	Durango Medical Plaza - Las Vegas, NV (1)		1		17,172		17,172		5.08	%		Fixed	Sep. 2017
	CareMeridian Rehabilitation - Phoenix, AZ (1)		1		6,936		6,936		5.08	%		Fixed	Sep. 2017
	Reliant Rehabilitation - Dallas, TX (1)		1		24,850		24,850		5.15	%		Fixed	Sep. 2017
	Select Rehabilitation - San Antonio, TX (1)		1		12,714		12,714		5.15	%		Fixed	Sep. 2017
	Spring Creek Medical Plaza - Tomball, TX (1)		1		7,477		7,477		5.15	%		Fixed	Sep. 2017
	Odessa Regional MOB - Odessa, TX		1		4,047		4,047		4.09	%	(2)	Fixed	Dec. 2016
	Methodist North MOB - Peoria, IL		1		13,544		13,544		3.99	%	(2)	Fixed	Dec. 2016
	University of Wisconsin Health MOB - Monona, WI		1		5,039		5,039		4	%		Fixed	Apr. 2017
	Reliant Rehabilitation - Houston, TX (1)		1		13,437		13,437		4.98	%		Fixed	Sep. 2017
	Village Healthcare Center - Santa Ana (1)		1		1,906		1,906		4.98	%		Fixed	Sep. 2017
	Sisters of Mercy Building - Springfield, MO		1		5,500		5,500		4.11	%		Fixed	Sep. 2017
	East Pointe Medical Plaza - Lehigh Acres, FL		1		5,260		5,260		4.11	%		Fixed	Sep. 2017
	Unitron Hearing Building - Plymouth, MN		1		4,000		4,000		4.11	%		Fixed	Sep. 2017
	Carson Tahoe MOB West - Carson City, NV		1		4,675		4,675		3.88	%	(2)	Fixed	Jun. 2017
	Aurora Health Care Portfolio		3		49,600		49,600		5.6	%		Fixed	Jan. 2017
	Princeton Village - Clackamas, OR		1		3,044		3,114		7.48	%		Fixed	Jan. 2031
	Pelican Pointe - Klamath Falls, OR		1		12,318		12,460		5.16	%		Fixed	Apr. 2022
	Fayette MOB - Fayetteville, GA		1		6,859		6,986		5.18	%		Fixed	Sep. 2015
	Garden House - Anderson, SC		1		8,048		8,149		4.86	%		Fixed	Dec. 2018
	Benton House - Covington, GA		1		8,030		8,121		5.26	%		Fixed	May-19
	Arbor Terrace - Asheville, SC		1		9,402		9,497		5.58	%		Fixed	Feb. 2018
	Arbor Terrace - Decatur, GA		1		10,860		10,970		5.57	%		Fixed	Jan. 2018
	Casa de Santa Fe - Rocklin, CA		1		20,491		—		4.71	%		Fixed	Oct. 2021
	Bay Medical Plaza - Lynn Haven, FL		1		9,579		—		6.61	%		Fixed	Aug. 2017
	Bay Medical Center - Panama City, FL		1		9,321		—		6.61	%		Fixed	Aug. 2017
	Legacy Heart Center - Plano, TX		1		5,863		—		5.76	%		Fixed	Oct. 2015
	Total		32		$	303,831	$	259,348	5.17	%	(3)
	_____________________________________
	-1	These mortgages, aggregating $106.2 million, represent the first, second and third tranches of a multi-tranche mortgage loan agreement to provide funding for a portfolio of eight properties. The mortgages for each of the properties are cross-collateralized with one another and in the event that the Company defaults on one of the mortgages, the lender may look to the other properties as collateral. During the three months ended September 30, 2014, the maturity date on these mortgages was extended to September 2017 from September 2015.
	-2	Fixed as a result of entering into a swap agreement.
	-3	Calculated on a weighted average basis for all mortgages outstanding as of September 30, 2014.
	The following table summarizes the scheduled aggregate principal payments on mortgage notes payable for the five years subsequent to September 30, 2014:
	(In thousands)		Future Principal
			Payments
	October 1, 2014 — December 31, 2014		$	393
	2015		13,937
	2016		20,936
	2017		200,596
	2018		27,778
	Thereafter		40,191
			$	303,831
	Some of the Company's mortgage notes payable agreements require compliance with certain property-level financial covenants including debt service coverage ratios. As of September 30, 2014 and December 31, 2013, the Company was in compliance with the financial covenants under its mortgage notes payable agreements.

Subordinated_Listing_Distribut

Subordinated Listing Distributed Derivative	9 Months Ended
	Sep. 30, 2014
Derivative Instruments and Hedging Activities Disclosure [Abstract]	'
Subordinated Listing Distribution Derivative	'
	Subordinated Listing Distribution Derivative
	Upon occurrence of the Listing, the SLP became entitled to begin receiving distributions of net sales proceeds pursuant to its special limited partner interest in the OP (the "SLP Interest") in an aggregate amount that is evidenced by the issuance of a note by the OP (the "Listing Note"). The Listing Note is equal to 15.0% of the amount, if any, by which (a) the average market value of the Company's outstanding common stock for the period 180 days to 210 days after the Listing, plus dividends paid by the Company prior to Listing, exceeds (b) the sum of the total amount of capital raised from stockholders during the Company's prior offering and the amount of cash flow necessary to generate a 6.0% annual cumulative, non-compounded return to such stockholders. Concurrently with the Listing, the Company, as general partner of the OP, caused the OP to enter into the Listing Note Agreement dated April 7, 2014 by and between the OP and the SLP (the "Listing Note Agreement"), and caused the OP to issue the Listing Note. The Listing Note is evidence of the SLP's right to receive distributions of net sales proceeds from the sale of the Company's real estate and real estate-related assets up to an aggregate amount equal to the principal balance of the Listing Note. Pursuant to the terms of the limited partnership agreement of the OP, the SLP has the right, but not the obligation, to convert all or a portion of the SLP Interest into OP units which are convertible into shares of the Company's common stock.
	Except as provided below, the principal amount of the Listing Note will be determinable based on the actual market value of the Company's outstanding common stock for the period 180 days to 210 days after the Listing and therefore the principal amount of the Listing Note is not yet definitive. Until the amount of the Listing Note can be determined, the Listing Note is considered a derivative, which is marked to fair value at each reporting date, with changes in the estimated value recorded in the consolidated statements of operations and comprehensive loss. The Listing Note fair value, as of September 30, 2014, was estimated using a Monte Carlo simulation, which uses a combination of observable and unobservable inputs and was adjusted to reflect the probability of the closing of the Merger (see Note 11 — Fair Value of Financial Instruments). As of September 30, 2014, the Listing Note had a fair value of $56.4 million, which is included in derivatives, at fair value on the accompanying consolidated balance sheet as of September 30, 2014. The final value of the Listing Note could differ materially from the current estimate.
	However, concurrently with the execution of the Merger Agreement, the OP and the SLP entered into an amendment to the Listing Note Agreement (the "Listing Note Amendment"), to provide that: (i) immediately prior to, and contingent upon, the closing of the Merger, the SLP will be deemed to have contributed its right to distributions from the OP pursuant to its SLP Interest, the amount of which distributions are evidenced by the Listing Note, to the OP in exchange for 5,613,374 OP units in the OP; and (ii) the Listing Note Agreement will terminate upon receipt by the SLP of such OP units. The Listing Note Amendment will, pursuant to its terms, automatically terminate and be of no further force or effect if the Merger Agreement is terminated in accordance with its terms.

Fair_Value_of_Financial_Instru

Fair Value of Financial Instruments	9 Months Ended
	Sep. 30, 2014
Fair Value Disclosures [Abstract]	'
Fair Value of Financial Instruments	'
	Fair Value of Financial Instruments
	The Company determines fair value based on quoted prices when available or through the use of alternative approaches, such as discounting the expected cash flows using market interest rates commensurate with the credit quality and duration of the instrument. This alternative approach also reflects the contractual terms of the instrument, as applicable, including the period to maturity, and uses observable market-based inputs, including interest rate curves and implied volatilities, and unobservable inputs, such as expected volatility. The guidance defines three levels of inputs that may be used to measure fair value:
	Level 1 — Quoted prices in active markets for identical assets and liabilities that the reporting entity has the ability to access at the measurement date.
	Level 2 — Inputs other than quoted prices included within Level 1 that are observable for the asset and liability or can be corroborated with observable market data for substantially the entire contractual term of the asset or liability.
	Level 3 — Unobservable inputs that reflect the entity's own assumptions that market participants would use in the pricing of the asset or liability and are consequently not based on market activity, but rather through particular valuation techniques.
	The determination of where an asset or liability falls in the hierarchy requires significant judgment and considers factors specific to the asset or liability. In instances where the determination of the fair value measurement is based on inputs from different levels of the fair value hierarchy, the level in the fair value hierarchy within which the entire fair value measurement falls is based on the lowest level input that is significant to the fair value measurement in its entirety. The Company evaluates its hierarchy disclosures each quarter and depending on various factors, it is possible that an asset or liability may be classified differently from quarter to quarter. However, the Company expects that changes in classifications between levels will be rare.
	Although the Company has determined that the majority of the inputs used to value its interest rate swaps fall within Level 2 of the fair value hierarchy, the credit valuation adjustments associated with those interest rate swaps utilize Level 3 inputs, such as estimates of current credit spreads, to evaluate the likelihood of default by the Company and its counterparties. However, as of September 30, 2014 and December 31, 2013, the Company has assessed the significance of the impact of the credit valuation adjustments on the overall valuation of its interest rate swap positions and has determined that the credit valuation adjustments are not significant to the overall valuation of the Company's interest rate swaps. As a result, the Company has determined that its interest rate swap valuations in their entirety are classified in Level 2 of the fair value hierarchy.
	The valuation of interest rate swaps is determined using a discounted cash flow analysis on the expected cash flows. This analysis reflects the contractual terms of the interest rate swaps, including the period to maturity, as well as observable market-based inputs, including interest rate curves and implied volatilities. In addition, credit valuation adjustments are incorporated into the fair values to account for the Company's potential nonperformance risk and the performance risk of the counterparties.
	The valuation of the OPP was determined using a Monte Carlo simulation. This analysis reflects the contractual terms of the OPP, including the vesting periods and total return hurdles, as well as observable market-based inputs, including interest rate curves, and unobservable inputs, such as expected volatility and a probability of the closing of the Merger. As a result, the Company has determined that its OPP valuation in its entirety is classified in Level 3 of the fair value hierarchy.
	The valuation of the Listing Note is determined using a Monte Carlo simulation. This analysis reflects the known inputs of the valuation of the Listing Note, including the gross share proceeds received and the sum of dividends paid prior to the Listing, as well as observable market-based inputs, including interest rate curves, implied probability of the closing of the Merger and unobservable inputs, such as expected volatility. As a result, the Company has determined that its Listing Note valuation in its entirety is classified in Level 3 of the fair value hierarchy.
	The Company has investments in common stock, redeemable preferred stock, a real estate income fund and senior notes that are traded in active markets and therefore, due to the availability of quoted market prices in active markets, the Company has classified these investments as Level 1 in the fair value hierarchy.
	The following table presents information about the Company's assets and liabilities (including derivatives that are presented net) measured at fair value on a recurring basis as of September 30, 2014 and December 31, 2013, aggregated by the level in the fair value hierarchy within which those instruments fall:
	(In thousands)	Quoted Prices in Active Markets				Significant Other Observable Inputs				Significant Unobservable Inputs				Total
		Level 1				Level 2				Level 3
	September 30, 2014
	Interest rate swaps	$	—			$	(233	)		$	—			$	(233	)
	Investment securities	$	1,587			$	—			$	—			$	1,587
	OPP (1)	$	—			$	—			$	(1,285	)		$	(1,285	)
	Listing Note	$	—			$	—			$	(56,400	)		$	(56,400	)
	December 31, 2013
	Interest rate swaps	$	—			$	(333	)		$	—			$	(333	)
	Investment securities	$	14,670			$	—			$	—			$	14,670
	__________________
	(1) The amount presented represents the fair value of all LTIP units issued under the OPP, of which $0.2 million and $0.7 million have been recorded in general and administrative expense on the consolidated statement of operations and comprehensive loss for the three and nine months ended September 30, 2014, respectively, and are presented as a liability on the consolidated balance sheet in accounts payable and accrued expenses.
	A review of the fair value hierarchy classification is conducted on a quarterly basis. Changes in the type of inputs may result in a reclassification for certain assets. There were no transfers between levels of the fair value hierarchy during the nine months ended September 30, 2014.
	Level 3 valuations
	The following is a reconciliation of the beginning and ending balance for the changes in instruments with Level 3 inputs in the fair value hierarchy for the nine months ended September 30, 2014:
	(In thousands)	OPP				Listing Note
	Beginning balance as of December 31, 2013	$	—			$	—
	Fair value at issuance	33,200				27,400
	Fair value adjustments	(31,915		)		29,000
	Ending balance as of September 30, 2014	$	1,285			$	56,400
	The following table provides quantitative information about the significant Level 3 inputs used:
	Financial Instrument	Fair Value at September 30, 2014				Principal Valuation Technique		Unobservable Inputs		Input Value
		(In thousands)
	Listing Note	$	56,400			Monte Carlo Simulation		Expected volatility		20.00%
								Merger Probability		95.00%
	OPP	$	1,285			Monte Carlo Simulation		Expected volatility		23.00%
								Merger Probability		95.00%
	The following discussion provides a description of the impact on a fair value measurement of a change in each unobservable input in isolation. For the relationship described below, the inverse relationship would also generally apply.
	Expected volatility is a measure of the variability in possible returns for an instrument, parameter or market index given how much the particular instrument, parameter or index changes in value over time. Generally, the higher the expected volatility of the underlying instrument, the wider the range of potential future returns. An increase in expected volatility, in isolation, would generally result in an increase in the fair value measurement of an instrument.
	Pursuant to the OPP Termination Agreement, the OPP will terminate without payment to the Advisor, contingent on the closing of the Merger (see Note 17 — Equity-Based Compensation). As such, all LTIP units previously issued under the OPP may be forfeited and any value associated with the OPP would be eliminated. The closing of the Merger also requires the Listing Note to be settled through the issuance of 5,613,374 OP units pursuant to the Listing Note Amendment, which will be converted into Ventas Class C units that are convertible into shares of Ventas Common Stock (see Note 2 — Merger Agreement). The probability input is a measure of the likelihood that the Merger will occur given legal and due diligence requirements that exist in order to close the Merger. An increase in the probability of the Merger, in isolation, would generally result in a decrease in the fair value of the OPP and an increase in the fair value of the Listing Note.
	Financial instruments not carried at fair value
	The Company is required to disclose the fair value of financial instruments for which it is practicable to estimate that value. The fair value of short-term financial instruments such as cash and cash equivalents, restricted cash, investment securities, other receivables, due to affiliates, accounts payable and dividends payable approximates their carrying value on the consolidated balance sheets due to their short-term nature. The fair values of the Company's remaining financial instruments that are not reported at fair value on the consolidated balance sheets are reported below:
				Carrying Amount at				Fair Value at				Carrying Amount at				Fair Value at
	(In thousands)	Level		September 30, 2014				September 30, 2014				December 31, 2013				December 31, 2013
	Mortgage notes payable and premiums, net (1)	3		$	307,443			$	316,664			$	262,117			$	266,242
	Credit facility	3		$	619,400			$	619,400			$	—			$	—
	Preferred equity investment	3		$	8,800			$	8,800			$	—			$	—
	________________
	(1) Carrying values include $303.8 million and $259.3 million mortgage notes payable and $3.6 million and $2.8 million net mortgage premiums as of September 30, 2014 and December 31, 2013, respectively.
	The fair value of the mortgage notes payable are estimated using a discounted cash flow analysis, based on the Advisor's experience with similar types of borrowing arrangements. Advances under the credit facility are considered to be reported at fair value, since its interest rate is considered a market rate and varies with changes in LIBOR.
	The Company estimates that the fair value of its preferred equity investment approximates cost, unless there is an indication of impairment in the investment or there has been a significant decline in the operations of the underlying facility. As of September 30, 2014, there is no indication that the investment has been impaired or that the operations of the underlying facility has declined.

Interest_Rate_Derivatives_and_

Interest Rate Derivatives and Hedging Activities	9 Months Ended
	Sep. 30, 2014
Derivative Instruments and Hedging Activities Disclosure [Abstract]	'
Interest Rate Derivatives and Hedging Activities	'
	Interest Rate Derivatives and Hedging Activities
	Risk Management Objective of Using Derivatives
	The Company may use derivative financial instruments, including interest rate swaps, caps, collars, options, floors and other interest rate derivative contracts, to hedge all or a portion of the interest rate risk associated with its borrowings. The principal objective of such arrangements is to minimize the risks and costs associated with the Company's operating and financial structure as well as to hedge specific anticipated transactions. The Company does not intend to utilize derivatives for speculative or other purposes other than interest rate risk management. The use of derivative financial instruments carries certain risks, including the risk that the counterparties to these contractual arrangements will not be able to perform under the agreements. To mitigate this risk, the Company only enters into derivative financial instruments with counterparties with high credit ratings and with major financial institutions with which the Company and its affiliates may also have other financial relationships.
	Cash Flow Hedges of Interest Rate Risk
	The Company's objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish this objective, the Company may use interest rate swaps and collars as part of its interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the receipt of variable-rate amounts from a counterparty in exchange for the Company making fixed-rate payments over the life of the agreements without exchange of the underlying notional amount. Such derivatives were used to hedge the variable cash flows associated with forecasted variable-rate debt. Interest rate collars designated as cash flow hedges involve the receipt of variable-rate amounts if interest rates rise above the cap strike rate on the contract and payments of variable-rate amounts if interest rates fall below the floor strike rate on the contract.
	The effective portion of changes in the fair value of derivatives designated and that qualify as cash flow hedges is recorded in accumulated other comprehensive income and is subsequently reclassified into earnings in the period that the hedged forecasted transaction affects earnings. The ineffective portion of the change in fair value of the derivatives is recognized directly in earnings.
	Amounts reported in accumulated other comprehensive income related to derivatives will be reclassified to interest expense as interest payments are made on the Company's variable-rate debt. During the next 12 months, the Company estimates that an additional $0.2 million will be reclassified from other comprehensive loss as an increase to interest expense.
	As of September 30, 2014 and December 31, 2013, the Company had the following outstanding interest rate derivatives that were designated as cash flow hedges of interest rate risk:
		September 30, 2014						December 31, 2013
	Interest Rate Derivative	Number of		Notional Amount				Number of		Notional Amount
		Instruments						Instruments
				(In thousands)						(In thousands)
	Interest rate swaps	3		$	22,266			3		$	22,266
	The table below presents the fair value of the Company's derivative financial instruments as well as their classification on the consolidated balance sheets as of September 30, 2014 and December 31, 2013:
	(In thousands)	Balance Sheet Location		September 30, 2014				December 31, 2013
	Derivatives designated as hedging instruments:
	Interest rate swaps	Derivatives, at fair value		$	(233	)		$	(333	)
	Derivatives in Cash Flow Hedging Relationships
	The table below details the location in the financial statements of the gain or loss recognized on interest rate derivatives designated as cash flow hedges for the three and nine months ended September 30, 2014 and 2013:
		Three Months Ended September 30,								Nine Months Ended September 30,
	(In thousands)	2014				2013				2014			2013
	Amount of income (loss) recognized in accumulated other comprehensive loss from interest rate derivatives (effective portion)	$	42			$	(139	)		$	(92	)	$	83
	Amount of loss reclassified from accumulated other comprehensive loss into income as interest expense (effective portion)	$	(65	)		$	(62	)		$	(192	)	$	(183	)
	Amount of gain (loss) recognized in income on derivative instruments (ineffective portion and amount excluded from effectiveness testing)	$	—			$	—			$	—		$	—
	Offsetting Derivatives
	The table below presents a gross presentation, the effects of offsetting, and a net presentation of the Company's interest rate derivatives as of September 30, 2014 and December 31, 2013. The net amounts of derivative assets or liabilities can be reconciled to the tabular disclosure of fair value. The table below provides the location that the fair value of derivative assets and liabilities are presented on the accompanying consolidated balance sheets:
													Gross Amounts Not Offset on the Balance Sheet
	Derivatives (In thousands)	Gross Amounts of Recognized Liabilities				Gross Amounts Offset on the Balance Sheet				Net Amounts of Liabilities presented on the Balance Sheet			Financial Instruments			Cash Collateral Posted		Net Amount
	September 30, 2014	$	(233	)		$	—			$	(233	)	$	—		$	—	$	(233	)
	December 31, 2013	$	(333	)		$	—			$	(333	)	$	—		$	—	$	(333	)
	Derivatives Not Designated as Hedges
	Derivatives not designated as hedges are not speculative. These derivatives may be used to manage the Company's exposure to interest rate movements and other identified risks but do not meet the strict hedge accounting requirements to be classified as hedging instruments. The Company does not have any hedging instruments that do not qualify for hedge accounting.
	Credit-risk-related Contingent Features
	The Company has agreements with its derivative counterparties that contain a provision whereby if the Company either defaults or is capable of being declared in default on any of its indebtedness, then the Company could also be declared in default on its derivative obligation.
	As of September 30, 2014, the fair value of derivatives in a liability position related to these agreements, including accrued interest, but excluding any adjustment for nonperformance risk related to these agreements, was $0.2 million. As of September 30, 2014, the Company has not posted any collateral related to these agreements and was not in breach of any agreement provisions. If the Company had breached any of these provisions, it could have been required to settle its obligations under the agreement at its aggregate termination value of $0.2 million at September 30, 2014.

Common_Stock

Common Stock	9 Months Ended
	Sep. 30, 2014
Stockholders' Equity Note [Abstract]	'
Common Stock	'
	Common Stock
	The Company listed its common stock on the NASDAQ under the symbol "HCT" on April 7, 2014. As of September 30, 2014 and December 31, 2013, the Company had 169.3 million and 180.5 million shares of common stock outstanding, respectively, including unvested restricted stock and shares issued under the DRIP.
	On April 7, 2014, the Company commenced the Tender Offer. The Tender Offer was completed on May 2, 2014 with the Company purchasing approximately 13.6 million shares of its common stock at a price of $11.00 per share, for an aggregate of $150.1 million, excluding fees and expenses relating to the Tender Offer and including fractional shares repurchased thereafter. The Company funded the Tender Offer using a draw on its Amended Facility.
	On April 11, 2014, the Company filed a universal shelf registration statement that was automatically effective upon filing. The Company intends to maintain the universal shelf registration statement pending the Effective Time of the Merger, at which time the Company intends to withdraw the shelf registration statement..
	On December 10, 2011, the board of directors authorized, and the Company declared, dividends payable to stockholders of record each day during the applicable period at a rate equal to $0.0018630137 per day, or $0.68 annually, per share of common stock beginning January 1, 2012. Following the Listing, dividends are paid to stockholders of record at the close of business on the 8th day of each month and payable on the 15th day of such month. Dividend payments are dependent on the availability of funds. The board of directors may reduce the amount of dividends paid or suspend dividend payments at any time and therefore dividend payments are not assured.
	On April 1, 2014, the Company provided notice to its stockholders that, pursuant to the terms of the DRIP, the board of directors approved an amendment to the DRIP that enables the Company to suspend the DRIP. Subsequently, the board of directors approved the suspension of the DRIP, effective March 30, 2014. The final issuance of shares of common stock pursuant to the DRIP in connection with the Company's March 2014 dividend was paid in April 2014.
	On March 30, 2014, the board of directors approved the termination of the Company's Share Repurchase Program ("SRP"). The Company processed all of the requests received under the SRP for the first quarter of 2014 and did not and will not process further requests. The following table reflects the cumulative number of shares repurchased under the Company's SRP through the end of the program on March 30, 2014:
		Number of Requests	Number of Shares Repurchased	Average Price per Share
	Cumulative repurchase requests as of December 31, 2013	122	386,968	$	9.77
	Requests made in 2014	22	69,476	9.85
	Cumulative repurchase requests as of the end of the program	144	456,444	$	9.79

Commitments_and_Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2014
Commitments and Contingencies Disclosure [Abstract]	'
Commitments and Contingencies	'
	Commitments and Contingencies
	Future Minimum Lease Payments
	The Company has entered into lease agreements related to certain acquisitions under leasehold interest arrangements. The following table reflects the minimum base cash rental payments due from the Company over the next five years and thereafter under these arrangements.  These amounts exclude contingent rent payments, as applicable, that may be payable based on provisions related to increases in annual rent based on exceeding certain economic indexes among other items.
	(In thousands)	Future Minimum
		Lease Payments
	October 1, 2014 — December 31, 2014	$	167
	2015	627
	2016	634
	2017	641
	2018	664
	Thereafter	23,553
		$	26,286
	Purchase Commitments
	In July 2013, the Company entered into a construction advance agreement and purchase and sale agreement to initially fund the construction of, and subsequently purchase upon construction completion and rent commencement, a medical office building in Kenosha, Wisconsin for $24.5 million. As of September 30, 2014, the Company has funded $1.7 million and $19.7 million for the land and construction in progress, respectively.
	Litigation
	In connection with the proposed acquisition by Ventas of all of the outstanding stock of the Company, purported shareholders of the Company have filed thirteen class action lawsuits in the Circuit Court for Baltimore City, Maryland and the Supreme Court of the State of New York and federal district court in Maryland naming the Company and its board of directors, among others, as defendants. The filed actions are: Holzer v. American Realty Capital Healthcare Trust, Inc. et al., Case No. 24-C-14-003553 (Md. Cir. Ct.), filed June 6, 2014; Romano v. American Realty Capital Healthcare Trust, Inc. et al., Case No. 24-C-14-003534 (Md. Cir. Ct.), filed June 6, 2014; Brenner v. American Realty Capital Healthcare Trust, Inc. et al., Case No. 24-C-14-003540 (Md. Cir. Ct.), filed June 9, 2014; Schindler v. Burns, et al., Index No. 671761/2014 (N.Y. Sup. Ct.), filed June 10, 2014; Frey v. American Realty Capital Healthcare Trust, Inc. et al., Index No. 651772/2014 (N.Y. Sup. Ct.), filed June 10, 2014; Hamill v. American Realty Capital Healthcare Trust, Inc. et al., Case No. 24-C-14-003636, (Md. Cir. Ct.), filed June 11, 2014; Stanley v. American Realty Capital Healthcare Trust, Inc. et al., Case No. 24-C-14-003664 (Md. Cir. Ct.), filed June 12, 2014; Shine v. American Realty Capital Healthcare Trust, Inc. et al., Case No. 24-C-14-003707 (Md. Cir. Ct.), filed June 13, 2014; Uhl v. American Realty Capital Healthcare Trust, Inc. et al., Case No. 24-C-14-003710 (Md. Cir. Ct.), filed June 13, 2014; Kuo v. American Realty Capital Healthcare Trust, Inc. et al., Case No. 24-C-14-003765 (Md. Cir. Ct), filed June 17, 2014; Flor v. American Realty Capital Healthcare Trust, Inc. et al., Case No. 24-C-14-003817 (Md. Cir. Ct.), filed June 19, 2014, Rosenzweig v. Schorsch et al., Case No. 1:14-CV-02019-GLR (U.S.D.C. - Dist. Md.) (Russell, D.J.), filed June 23, 2014; and Abbasi, et al. v. American Realty Capital Healthcare Trust, Inc. et al., Case No. 24-C-14-004104 (Md. Cir. Ct.), filed July 9, 2014. The Stanley, Shine, Kuo, Rosenzweig and Abbasi complaints also assert derivative claims on behalf of the Company against the individual defendants. On October 10, 2014, lead plaintiffs in the Maryland state court action filed a "Consolidated Amended Derivative and Direct Class Action Complaint," asserting direct and directive claims, inter alia, of breach of fiduciary duty arising from the proposed acquisition of the Company by Ventas, as well as claims for breach of the duty of candor, unjust enrichment, corporate waste and aiding and abetting fiduciary breaches and seek (i) to enjoin the proposed acquisition and (ii) recover damages if the proposed acquisition is completed. There have been no other material court filings in any of these matters.
	The Company believes that such lawsuits are without merit, but the ultimate outcome of such matter cannot be predicted with certainty. Because the lawsuits are in their early stages, neither the outcome of the lawsuits nor an estimate of a probable loss or any reasonable possible losses are determinable at this time. No provisions for such losses have been recorded in the accompanying consolidated financial statements for the three and nine months ended September 30, 2014. An adverse judgment for monetary damages could have a material adverse effect on the operations and liquidity of the Company. A preliminary injunction could delay or jeopardize the completion of the Merger, and an adverse judgment granting permanent injunctive relief could indefinitely enjoin completion of the Merger. All defendants believe that the claims are without merit and are defending against them vigorously. Additional lawsuits arising out of or related to the Merger Agreement may be filed in the future. As of September 30, 2014, there were no other material legal proceedings pending or known to be contemplated against the Company.
	Environmental Matters
	In connection with the ownership and operation of real estate, the Company may potentially be liable for costs and damages related to environmental matters. As of September 30, 2014, the Company maintains environmental insurance for its properties that provides coverage for potential environmental liabilities, subject to the policy's coverage conditions and limitations. The Company has not been notified by any governmental authority of any non-compliance, liability or other claim, and is not aware of any other environmental condition that it believes will have a material adverse effect on the consolidated results of operations and comprehensive loss.

Related_Party_Transactions_and

Related Party Transactions and Arrangements	9 Months Ended
	Sep. 30, 2014
Related Party Transactions [Abstract]	'
Related Party Transactions and Arrangements	'
	Related Party Transactions and Arrangements
	The SLP, an entity controlled by the Sponsor, owned 20,000 shares of the Company's outstanding common stock as of September 30, 2014 and December 31, 2013.
	The Advisor, as the holder of Class B units, had the right to make a capital contribution to the OP in exchange for OP units. Pursuant to a contribution and exchange agreement entered into between the Advisor and the OP dated April 7, 2014 (the "Contribution and Exchange Agreement"), the Advisor contributed $0.8 million in cash to the OP in exchange for 83,333 OP units of the OP (see Note 19  — Non-Controlling Interests).
	During the nine months ended September 30, 2014, the Company invested $3.0 million in a real estate income fund managed by an affiliate of the Sponsor (see Note 6 — Investment Securities). During the three and nine months ended September 30, 2014, the Company sold a portion of its investment in the real estate income fund for proceeds of $1.5 million and recorded a gain on the sale of approximately $37,000 in the consolidated statement of operations and comprehensive loss. As of September 30, 2014, the Company's investment in the real estate income fund was $1.6 million. There is no obligation to purchase any additional shares and the shares can be sold at any time.
	Fees Paid in Connection with the IPO
	The Dealer Manager was paid fees and compensation in connection with the sale of the Company's common stock in the IPO. The Dealer Manager received a selling commission of up to 7.0% of gross offering proceeds before reallowance of commissions earned by participating broker-dealers. In addition, the Dealer Manager received up to 3.0% of the gross proceeds from the sale of common stock, before reallowance to participating broker-dealers, as a dealer manager fee. The Dealer Manager was permitted to reallow its dealer manager fee to participating broker-dealers, based on such factors as the volume of shares sold by respective participating broker-dealers and marketing support incurred as compared to those of other participating broker-dealers. The following table details total selling commissions and dealer manager fees incurred and receivable from the Dealer Manager as of and for the periods presented:
		Three Months Ended					Nine Months Ended				Receivable (1) as of
		September 30,					September 30,				September 30,		December 31,
	(In thousands)	2014		2013			2014		2013		2014		2013
	Total commissions and fees incurred from the Dealer Manager	$	—	$	(48	)	$	—	$	117,377	$	—	$	(18	)
	_____________________
	(1) Includes reimbursements received for selling commissions and dealer manager fees as a result of share purchase cancellations related to common stock sales prior to the close of the IPO
	The Advisor and its affiliates received compensation and reimbursement for services provided in connection with the IPO. Effective March 1, 2013, the Company utilized transfer agent services provided by an affiliate of the Dealer Manager. All offering costs related to the IPO incurred by the Company, or its affiliated entities, on behalf of the Company were charged to additional paid-in capital on the accompanying consolidated balance sheets during the IPO. The following table details offering costs and reimbursements incurred from and payable to the Advisor and Dealer Manager as of and for the periods presented:
		Three Months Ended					Nine Months Ended				Payable as of
		September 30,					September 30,				September 30,		December 31,
	(In thousands)	2014		2013			2014		2013		2014		2013
	Fees and expense reimbursements incurred from the Advisor and Dealer Manager	$	—	$	—		$	—	$	1,901	$	—	$	—
	Fees Paid in Connection With the Operations of the Company
	The Advisor is paid an acquisition fee equal to 1.0% of the contract purchase price of each acquired property and 1.0% of the amount advanced for a loan or other investment and is reimbursed for acquisition costs incurred in the process of acquiring properties, which is expected to be approximately 0.5% of the contract purchase price of each acquired property and 0.5% of the amount advanced for a loan or other investment. The total of all acquisition fees, acquisition expenses and financing coordination fees (as defined below), with respect to the Company's portfolio of investments, did not exceed 4.5% of the contract purchase price of the Company's portfolio as measured at the close of the acquisition phase. On April 7, 2014, in connection with the Listing, the Company entered into the Third Amended and Restated Advisory Agreement (the "Amended Advisory Agreement") by and among the Company, the OP and the Advisor, which, among other things, terminates the acquisition fee 180 days after the Listing, or October 4, 2014 (the "Termination Date"), except for fees with respect to properties under contract, letter of intent or under negotiation as of the Termination Date.
	If the Advisor provides services in connection with the origination or refinancing of any debt that the Company obtains and uses to acquire properties or to make other permitted investments, or that is assumed, directly or indirectly, in connection with the acquisition of properties, the Company pays the Advisor a financing coordination fee equal to 1.0% of the amount available or outstanding under such financing, subject to certain limitations. In accordance with the Amended Advisory Agreement, the financing coordination fee terminates on the Termination Date, except for fees with respect to properties under contract, letter of intent or under negotiation as of the Termination Date.
	In connection with providing strategic advisory services related to certain portfolio acquisitions, the Company has entered into arrangements in which the investment banking division of the Dealer Manager receives a transaction fee of 0.25% of the transaction value for such portfolio acquisition transactions. Should the Dealer Manager provide strategic advisory services related to additional portfolio acquisition transactions, the Company will enter into new arrangements with the Dealer Manager on such terms as may be agreed upon between the two parties.
	Until the Listing, in respect of the asset management subordination, the Advisor was entitled to Class B units equal to: (i) the excess of (A) the product of (y) the cost of assets multiplied by (z) 0.1875% over (B) any amounts payable as an oversight fee (as described below) for such calendar quarter; divided by (ii) the per share price in the primary portion of the IPO, excluding commissions and dealer manager fees. In respect of this arrangement, the Company caused the OP to issue (subject to periodic approval by the board of directors) to the Advisor performance-based restricted partnership units of the OP designated as "Class B units," which were intended to be profit interests and vest, and no longer be subject to forfeiture, at such time as: (x) the value of the OP's assets plus all dividends made equaled or exceeded the total amount of capital contributed by investors plus a 6% cumulative, pre-tax, non-compounded annual return thereon (the "economic hurdle"); (y) any one of the following occurs: (1) the termination of the advisory agreement by an affirmative vote of a majority of the Company's independent directors without cause; (2) a listing; or (3) another liquidity event; and (z) the Advisor is still providing advisory services to the Company (the "performance condition"). The value of issued Class B units was determined and expensed when the Company deemed the achievement of the performance condition to be probable, which occurred as of the Listing. As of April 7, 2014, in aggregate, the board of directors had approved the issuance of 1,360,362 Class B units to the Advisor in connection with this arrangement. The Advisor received dividends on unvested Class B units equal to the dividend rate received on the Company's common stock. Such dividends on issued Class B units are included in general and administrative expenses in the consolidated statement of operations and comprehensive loss. The performance condition related to these Class B units was satisfied upon completion of the Listing, which resulted in $12.9 million of expense on April 7, 2014, which is included in vesting of Class B units for asset management services expense on the consolidated statement of operations and comprehensive loss. On April 7, 2014, the Class B units were converted to OP units on a one-to-one basis.
	In accordance with the Amended Advisory Agreement, the asset management fee was amended to 0.50% per annum of average invested assets up to $3.0 billion and 0.40% per annum of average invested assets above $3.0 billion. The Amended Advisory Agreement also permits the asset management fee to be paid in the form of cash, OP units and shares of restricted common stock of the Company, or a combination thereof, at the Advisor's election.
	Concurrently with the execution of the Merger Agreement, the Company entered into an amendment, whereby the parties have agreed to terminate the Amended Advisory Agreement immediately prior to, and contingent upon, the closing of the Merger.
	Unless the Company contracts with a third party, the Company pays the Property Manager a property management fee of up to 1.5% of gross revenues from the Company's stand-alone single-tenant net leased properties and up to 2.5% of gross revenues from all other types of properties, respectively, plus market-based leasing commission applicable to the geographic location of each property.  The Company also reimburses the affiliate for property level expenses. If the Company contracts directly with third parties for such services, the Company pays them customary market fees and pays the Property Manager an oversight fee of up to 1.0% of the gross revenues of the applicable property. In no event will the Company pay the Property Manager or any affiliate both a property management fee and an oversight fee with respect to any particular property. Concurrently with the execution of the Merger Agreement, the Company entered into an amendment (the "Property Management Agreement Amendment"). Under the Property Management Agreement Amendment, the parties have agreed to terminate the property management agreement immediately prior to, and contingent upon, the closing of the Merger. The Property Management Agreement Amendment will, pursuant to its terms, automatically terminate and be of no further force or effect if the Merger Agreement is terminated in accordance with its terms.
	Effective March 1, 2013, the Company entered into an agreement with the Dealer Manager to provide strategic advisory and investment banking services required in the ordinary course of the Company's business, such as performing financial analysis, evaluating publicly traded comparable companies and assisting in developing a portfolio composition strategy, a capitalization structure to optimize future liquidity options and structuring operations. Strategic advisory fees were amortized over the term of the IPO and included in acquisition and transaction related costs on the consolidated statement of operations and comprehensive loss. The Dealer Manager and its affiliates also provide transfer agency services, as well as transaction management and other professional services. After the close of the IPO, these fees were included in general and administrative expenses on the consolidated statement of operations and comprehensive loss during the period the service was provided.
	The following table details amounts incurred, forgiven and payable to related parties in connection with the Company's operations-related services described above as of and for the periods presented:
		Three Months Ended September 30,									Nine Months Ended September 30,									Payable as of
		2014					2013				2014					2013				September 30,		December 31,
	(In thousands)	Incurred		Forgiven			Incurred		Forgiven		Incurred		Forgiven			Incurred		Forgiven		2014		2013
	One-time fees and reimbursements:
	Acquisition fees and related cost reimbursements	$	1,151	$	—		$	697	$	—	$	5,684	$	—		$	3,577	$	—	$	—	$	—
	Transaction fee	—		—			306		—		—		—			306		—		—		—
	Financing coordination fees	—		—			7,784		—		361		—			7,942		—		—		—
	Other expense reimbursements	—		—			—		—		—		—			19		—		—		—
	Ongoing fees:
	Asset management services (1)	2,711		—			—		—		5,063		—			—		—		—		—
	Property management and leasing fees	—		793			—		370		—		2,105			—		861		—		—
	Transfer agent and other professional fees	350		—			621		—		1,547		—			847		—		213		235
	Strategic advisory fees	—		—			—		—		—		—			920		—		—		—
	Dividends on Class B Units	—		—			63		—		151		—			117		—		—		—
	Total related party operation fees and reimbursements	$	4,212	$	793		$	9,471	$	370	$	12,806	$	2,105		$	13,728	$	861	$	213	$	235
	________________
	(1) Prior to the Listing, the Company caused the OP to issue the Advisor restricted performance based Class B units for asset management services, which vested with the Listing. Amounts reflected in the table reflect asset management services following the Listing as described above.
	The Company reimburses the Advisor's costs of providing administrative services, subject to the limitation that it will not reimburse the Advisor for any amount by which its operating expenses (including the asset management fee) at the end of the four preceding fiscal quarters exceeds the greater of (a) 2% of average invested assets, or (b) 25% of net income other than any additions to reserves for depreciation, bad debt or other similar non-cash reserves and excluding any gain from the sale of assets for that period. Additionally, the Company will not reimburse the Advisor for personnel costs in connection with services for which the Advisor receives acquisition fees or real estate commissions. No reimbursement was incurred from the Advisor for providing administrative services, including any reimbursement for compensation to named officers of the Company, for the three and nine months ended September 30, 2014 or 2013.
	In order to improve operating cash flows and the ability to pay dividends from operating cash flows, the Advisor and the Property Manager agreed to waive certain fees including property management fees. Because the Advisor and the Property Manager waived certain fees, cash flows from operations that would have been paid to the Advisor and the Property Manager were available to pay dividends to stockholders. The fees that were forgiven are not deferrals and accordingly, will not be paid to the Advisor or the Property Manager in any subsequent periods. In certain instances, to improve the Company's working capital, the Advisor may elect to absorb a portion of the Company's general and administrative costs. No such fees were absorbed during the three and nine months ended September 30, 2014 or the three months ended September 30, 2013. For the nine months ended September 30, 2013, the Advisor absorbed $0.3 million of the Company's general and administrative costs. The Company did not have a receivable due from the Advisor related to absorbed general and administrative costs as of September 30, 2014 and December 31, 2013. These absorbed costs are presented net in the accompanying consolidated statements of operations and comprehensive loss.
	Fees Incurred in Connection with the Liquidation or Listing of the Company's Real Estate Assets
	Fees Incurred in Connection with the Listing
	In December 2013, the Company entered into a transaction management agreement with RCS Advisory Services, LLC, an entity owned by the Dealer Manager, to provide strategic alternatives transaction management services through the occurrence of a liquidity event and a-la-carte services thereafter. The Company agreed to pay $3.0 million pursuant to this agreement. During the nine months ended September 30, 2014, the Company incurred $1.5 million in fees pursuant to this agreement, which includes amounts for services provided in preparation for the Listing, and is included in acquisition and transaction related costs on the consolidated statement of operations and comprehensive loss. No such amounts were incurred during the three months ended September 30, 2014 or the three and nine months ended September 30, 2013. The Company incurred $1.5 million in fees pursuant to this arrangement during the year ended December 31, 2013 which were included in acquisition and transaction related costs in the consolidated statement of operations and comprehensive loss. Thus the Company does not owe the Dealer Manager any more fees pursuant to this agreement.
	In December 2013, the Company entered into an information agent and advisory services agreement with the Dealer Manager and American National Stock Transfer, LLC, an entity owned by the Dealer Manager, to provide in connection with a liquidity event, advisory services, educational services to external and internal wholesalers, communication support as well as proxy, tender offer or redemption and solicitation services. The Company agreed to pay $1.9 million pursuant to this agreement. During the nine months ended September 30, 2014, the Company incurred $1.3 million of these fees pursuant to this agreement, which includes amounts for services provided in preparation for the Tender Offer, and is included in additional paid in capital on the consolidated balance sheet. No such amounts were incurred during the three months ended September 30, 2014 or the three and nine months ended September 30, 2013. The Company incurred $0.6 million in fees pursuant to this arrangement during the year ended December 31, 2013 which were included in acquisition and transaction related costs in the consolidated statement of operations and comprehensive loss.
	The investment banking division of the Dealer Manager provided the Company with strategic and financial advice and assistance in connection with (i) a possible sale transaction involving the Company (ii) the possible listing of the Company's securities on a national securities exchange, and (iii) a possible acquisition transaction involving the Company. The Dealer Manager received a listing advisory fee equal to an amount equal to 0.25% of the transaction value. During the nine months ended September 30, 2014, the Company incurred $6.4 million in connection with this agreement, which is included in acquisition and transaction related expenses on the consolidated statement of operations and comprehensive loss. No such amounts were incurred during the three months ended September 30, 2014 or the three and nine months ended September 30, 2013.
	During the nine months ended September 30, 2014, the Company also incurred $1.5 million of expenses with affiliated entities relating to general legal, marketing and sales services provided in connection with the Listing and other non-recurring transactions. These expenses are included in acquisition and transaction related costs in the consolidated statement of operations and comprehensive loss. No such amounts were incurred during the three months ended September 30, 2014 or the three and nine months ended September 30, 2013.
	Fees Incurred in Connection with the Merger
	In May 2014, the Company entered into a transaction management agreement with RCS Advisory Services, LLC, an entity owned by the Dealer Manager, to provide, in connection with the Merger, strategic alternatives transaction management services through the occurrence of a sale transaction and a-la-carte services thereafter. The Company agreed to pay $3.0 million pursuant to this agreement. During the three and nine months ended September 30, 2014, the Company incurred $1.0 million and $3.0 million, respectively, in fees pursuant to this agreement, which includes amounts for services provided in preparation for the Merger, and is included in acquisition and transaction related costs on the consolidated statement of operations and comprehensive loss. Accounts payable and accrued expenses on the consolidated balance sheet as of September 30, 2014 includes $3.0 million related to this agreement. No such amounts were incurred during three and nine months ended September 30, 2013.
	In May 2014, the Company entered into an information agent and advisory services agreement with the Dealer Manager and American National Stock Transfer, LLC, an entity owned by the Dealer Manager, to provide in connection with the Merger, advisory services, educational services to external and internal wholesalers and communication support. The Company agreed to pay $1.9 million pursuant to this agreement. During the three and nine months ended September 30, 2014, the Company incurred $1.3 million and $1.9 million, respectively, of these fees pursuant to this agreement, which includes amounts for services provided in preparation for the Merger, and is included in acquisition and transaction related costs on the consolidated statement of operations and comprehensive loss. Accounts payable and accrued expenses on the consolidated balance sheet as of September 30, 2014 includes $1.5 million related to this agreement. No such amounts were incurred during the three and nine months ended September 30, 2013.
	The investment banking division of the Dealer Manager provides the Company with strategic and financial advice and assistance in connection with a possible sale transaction involving the Company. The Dealer Manager will receive a transaction advisory fee equal to the greatest of (i) an amount equal to 0.25% of the transaction value, (ii) $1.0 million and (iii) the highest fee payable to any co-bookrunner (or comparable person) in connection with the transaction. If the possible sale transaction does not occur, the Dealer Manger will receive a base advisor services fee of $1.0 million on the earlier of (a) the date the Dealer Manager resigns or is terminated for cause and (b) 18 months from the date of any other termination of this agreement by the Company. During the three and nine months ended September 30, 2014, the Company incurred $1.0 million in connection with this agreement, which is included in acquisition and transaction related costs on the consolidated statement of operations and comprehensive loss. This amount is included in accounts payable and accrued expenses on the consolidated balance sheet as of September 30, 2014. No such amounts were incurred during the three and nine months ended September 30, 2013.
	During the three and nine months ended September 30, 2014, the Company also incurred $0.1 million and $0.2 million, respectively, of expenses with affiliated entities relating to legal, consulting and other expenses provided in connection with the Merger. These expenses are included in acquisition and transaction related costs in the consolidated statement of operations and comprehensive loss. Accounts payable and accrued expenses on the consolidated balance sheet as of September 30, 2014 includes $0.1 million related to these expenses. No such amounts were incurred during the three and nine months ended September 30, 2013.
	Other Liquidation Related Fees
	The Company will pay a brokerage commission on the sale of property, not to exceed the lesser of 2.0% of the contract sale price of the property and 50.0% of the total brokerage commission paid if a third party broker is also involved; provided, however, that in no event may the real estate commissions paid to the Advisor, its affiliates and unaffiliated third parties exceed the lesser of 6.0% of the contract sales price and a reasonable, customary and competitive real estate commission, in light of the size, type and location of the property, in each case, payable to the Advisor or its affiliates, as determined by a majority of the independent directors. No such fees were incurred during the three and nine months ended September 30, 2014 or 2013.
	Concurrent with the Listing, the OP entered into the Listing Note (see Note 10 — Subordinated Listing Distribution Derivative) and the OPP (see Note 17 — Equity-Based Compensation).
	In connection with the Listing and the Amended Advisory Agreement, the Company terminated the subordinated termination fee that would be due to the Advisor in the event of termination of the advisory agreement.

Economic_Dependency

Economic Dependency	9 Months Ended
	Sep. 30, 2014
Economic Dependency [Abstract]	'
Economic Dependency	'
	Economic Dependency
	Under various agreements, the Company has engaged or will engage the Advisor and its affiliates and entities under common control with our Advisor to provide certain services that are essential to the Company, including asset management services, supervision of the management and leasing of properties owned by the Company, asset acquisition and disposition decisions, transfer agency services, as well as other administrative responsibilities for the Company including accounting services, transaction management services and investor relations.
	As a result of these relationships, the Company is dependent upon the Advisor and its affiliates. In the event that these companies are unable to provide the Company with the respective services, the Company will be required to find alternative providers of these services.

EquityBased_Compensation

Equity-Based Compensation	9 Months Ended
	Sep. 30, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'
Equity-Based Compensation	'
	Equity-Based Compensation
	Stock Option Plan
	The Company has a stock option plan (the "Plan") which authorizes the grant of nonqualified stock options to the Company's independent directors, officers, advisors, consultants and other personnel subject to the absolute discretion of the board of directors and the applicable limitations of the Plan. The exercise price for all stock options granted under the Plan was fixed at $10.00 per share until the Listing, and thereafter the exercise price for stock options granted to the independent directors will be equal to the fair market value of a share on the last business day preceding the annual meeting of stockholders. Upon a change in control, unvested options will become fully vested and any performance conditions imposed with respect to the options will be deemed to be fully achieved. A total of 0.5 million shares have been authorized and reserved for issuance under the Plan. As of September 30, 2014 and December 31, 2013, no stock options were issued under the Plan. In connection with the Merger Agreement, the Company has agreed to terminate the Plan, contingent on the closing of the Merger.
	Restricted Share Plan
	The Company's employee and director incentive restricted share plan ("RSP") provides the Company with the ability to grant awards of restricted shares to the Company's directors, officers and employees (if the Company ever has employees), employees of the Advisor and its affiliates, employees of entities that provide services to the Company, directors of the Advisor or of entities that provide services to the Company, certain consultants to the Company and the Advisor and its affiliates or to entities that provide services to the Company.
	Prior to the Listing, the RSP provided for the automatic grant of 3,000 restricted shares of common stock to each of the independent directors, without any further action by the Company's board of directors or the stockholders, on the date of initial election to the board of directors and on the date of each annual stockholder's meeting. Restricted stock issued to independent directors vested over a five-year period following the first anniversary of the date of grant in increments of 20% per annum.  Subsequent to the Listing, the Company amended the RSP to, among other things, remove the fixed amount of shares that are automatically granted to the independent directors. Under the amended RSP, the annual amount granted to the independent directors is determined by the board of directors. Generally, such awards provide for accelerated vesting of (i) all unvested shares upon a change in control or a termination without cause and (ii) the portion of the unvested shares scheduled to vest in the year of termination upon a voluntary termination or failure to be re-elected to the board.
	Prior to March 30, 2014, the total number of common shares granted under the RSP could not exceed 5.0% of the Company's outstanding shares of common stock on a fully diluted basis at any time, and in any event could not exceed 7.5 million shares (as such number may be adjusted for stock splits, stock dividends, combinations and similar events). On March 30, 2014, the Company adopted an amendment to the Company's RSP to increase the number of shares of the Company's capital stock, par value $0.01 per share, available for awards thereunder to 10.0% of the Company's outstanding shares of stock on a fully diluted basis at any time. The amendment also eliminated the RSP limit of 7.5 million shares of stock.
	Restricted shares may not, in general, be sold or otherwise transferred until restrictions are removed and the shares have vested. Holders of restricted shares may receive cash dividends prior to the time that the restrictions on the restricted shares have lapsed. Any dividends payable in shares of common stock shall be subject to the same restrictions as the underlying restricted shares. In connection with the Merger Agreement, the Company has agreed to terminate the RSP, contingent on the closing of the Merger.
	The following table reflects restricted share award activity to the Company's board of directors for the nine months ended September 30, 2014:
		Number of Restricted Shares		Weighted-Average Issue Price
	Unvested, December 31, 2013	18,000		$	9.23
	Granted	225,905		10.45
	Vested (1)	(18,000	)	9.23
	Unvested, September 30, 2014	225,905		$	10.45
	______________________
	(1) Previously granted unvested restricted stock outstanding vested as of the Listing.
	As of September 30, 2014, the Company had $1.7 million of unrecognized compensation cost related to unvested restricted share awards granted under the Company's RSP.
	The fair value of the restricted shares, based on the price per share in the IPO or the per share closing price on the NASDAQ subsequent to the IPO, is expensed over the vesting period of three or five years and included in general and administrative expense in the consolidated statement of operations and comprehensive loss. Compensation expense related to restricted stock was $0.6 million and approximately $13,000 for the three months ended September 30, 2014 and 2013, respectively. Compensation expense related to restricted stock was $0.7 million and approximately $31,000 for the nine months ended September 30, 2014 and 2013, respectively.
	Compensation expense related to the vesting of restricted stock in connection with the Listing of $0.1 million was recorded in acquisition and transaction costs in the consolidated statement of operations and comprehensive loss for the nine months ended September 30, 2014.
	Multi-Year Outperformance Plan
	On the OPP Effective Date in connection with the Listing, the Company entered into the OPP with the OP and the Advisor. Under the OPP, the Advisor was issued 9,219,108 LTIP units in the OP with a maximum award value on the issuance date equal to 5.0% of the Company's market capitalization (the "OPP Cap"). The LTIP units are structured as profits interest in the OP. Concurrently with the execution of the Merger Agreement, the Company, the OP and the Advisor entered into an agreement (the "OPP Termination Agreement") terminating the OPP. Under the OPP Termination Agreement, the OPP will terminate without payment to the Advisor, contingent on the closing of the Merger.
	If the Merger is not completed, the Advisor may be eligible to earn a number of LTIP units with a value equal to a portion of the OPP Cap upon the first, second and third anniversaries of the OPP Effective Date based on the Company's achievement of certain levels of total return to its stockholders ("Total Return"), including both share price appreciation and common stock dividends, as measured against a peer group of companies, as set forth below, for the three-year performance period commencing on the OPP Effective Date (the "Three-Year Period"); each 12-month period during the Three-Year Period (each, a "One-Year Period"); and the initial 24-month period of the Three-Year Period (the "Two-Year Period"), as follows:
				Performance Period		Annual Period	Interim Period
	Absolute Component: 4% of any excess Total Return attained above an absolute hurdle measured from the beginning of such period:			21%		7%	14%
	Relative Component: 4% of any excess Total Return attained above the Total Return for the performance period of the Peer Group*, subject to a ratable sliding scale factor as follows based on achievement of cumulative Total Return measured from the beginning of such period:
		•	100% will be earned if cumulative Total Return achieved is at least:	18%		6%	12%
		•	50% will be earned if cumulative Total Return achieved is:	—%		—%	—%
		•	0% will be earned if cumulative Total Return achieved is less than:	—%		—%	—%
		•	a percentage from 50% to 100% calculated by linear interpolation will be earned if the cumulative Total Return achieved is between:	0% - 18%		0% - 6%	0%- 12%
	____________________
	*The "Peer Group" is comprised of the companies in the SNL US REIT Healthcare Index.
	The potential outperformance award is calculated at the end of each One-Year Period, the Two-Year Period and the Three-Year Period. The award earned for the Three-Year Period is based on the formula in the table above less any awards earned for the Two-Year Period and One-Year Periods, but not less than zero; the award earned for the Two-Year Period is based on the formula in the table above less any award earned for the first and second One-Year Period, but not less than zero. Any LTIP units that are unearned at the end of the performance period will be forfeited.
	Until such time as the LTIP units are fully vested in accordance with the provisions of the OPP, the LTIP units are entitled to dividends equal to 10% of the dividends made on OP units. The Company paid $0.3 million in dividends related to the LTIP units during the three and nine months ended September 30, 2014, which is included in general and administrative expenses on the consolidated statement of operations and comprehensive loss. After the LTIP units are fully vested, they are entitled to a catch-up dividend and then the same dividends as the OP units. At the time the Advisor's capital account with respect to the LTIP units is economically equivalent to the average capital account balance of the OP units and has been earned and has been vested for 30 days, the applicable LTIP units will automatically convert into OP units on a one-to-one basis. The OPP provides for early calculation of LTIP units earned and for the accelerated vesting of any earned LTIP units in the event the Advisor is terminated or in the event the Company incurs a change in control, in either case prior to the end of the Three-Year Period.
	Because the Advisor can terminate at any time and receive the value of the award at the next anniversary date, the estimated value of the award as of the first anniversary was expensed on the OPP Effective Date and the estimated value of the award on the second and third anniversaries is being amortized over the first year and first two years of the OPP, respectively. The estimated fair value of the award at each anniversary date is determined using a Monte Carlo simulation with certain inputs including probability of the Merger (see Note 11 — Fair Value of Financial Instruments). The fair value of the award and related expense is adjusted each reporting period for changes in the estimated value. The Company recorded expenses related to the OPP of $0.2 million and $0.7 million for the three and nine months ended September 30, 2014, respectively, which are included in general and administrative expenses on the consolidated statement of operations and comprehensive loss. Because the award can be settled in cash, the related liability is included in accounts payable and accrued expenses on the consolidated balance sheet.
	Other Share-Based Compensation
	Until the Listing, the Company could issue common stock in lieu of cash to pay fees earned by the Company's directors at the respective director's election. There are no restrictions on the shares issued. There were no such shares issued during the nine months ended September 30, 2014. During the nine months ended September 30, 2013, the Company issued 1,667 shares in lieu of payment of approximately $15,000 in cash.

Net_Loss_Per_Share

Net Loss Per Share	9 Months Ended
	Sep. 30, 2014
Earnings Per Share [Abstract]	'
Net Loss Per Share	'
	Net Loss Per Share
	The following is a summary of the basic and diluted net loss per share computation for the three and nine months ended September 30, 2014 and 2013:
		Three Months Ended September 30,							Nine Months Ended September 30,
		2014				2013			2014			2013
	Net loss attributable to stockholders (in thousands)	$	(12,121	)		$	(5,475	)	$	(116,445	)	$	(12,339	)
	Basic and diluted weighted average shares outstanding	169,090,342				178,231,121			175,234,437			142,163,876
	Basic and diluted net loss per share attributable to stockholders	$	(0.07	)		$	(0.03	)	$	(0.66	)	$	(0.09	)
	The Company had the following common share equivalents as of September 30, 2014 and 2013, which were excluded from the calculation of diluted loss per share attributable to stockholders as the effect would have been antidilutive:
		September 30,
		2014			2013
	Unvested restricted stock	225,905			22,200
	OP units	1,443,897			202
	LTIP units	9,219,108			—
	Class B units	—			441,735
	Total common stock equivalents	10,888,910			464,137

NonControlling_Interests

Non-Controlling Interests	9 Months Ended
	Sep. 30, 2014
Noncontrolling Interest [Abstract]	'
Non-Controlling Interests	'
	Non-Controlling Interests
	The Company is the sole general partner of the OP and holds the majority of OP units. The Advisor, a limited partner, held 202 OP units as of December 31, 2013, which represented a nominal percentage of the aggregate OP ownership. On April 7, 2014, 1,360,362 Class B units that were previously issued to the Advisor for asset management services were converted to OP units on a one-to-one basis. Additionally, the Advisor, as the holder of Class B units, had the right to make a capital contribution to the OP in exchange for OP units. Pursuant to the Contribution and Exchange Agreement, the Advisor contributed $0.8 million in cash to the OP in exchange for 83,333 OP units of the OP. As of September 30, 2014, the Advisor held 1,443,897 OP units. There were $0.2 million and $0.4 million of OP unit dividends paid to the Advisor during the three and nine months ended September 30, 2014, respectively.
	A holder of OP units has the right to convert OP units for the cash value of a corresponding number of shares of the Company's common stock or a corresponding number of shares of the Company's common stock, at the Company's election, in accordance with the limited partnership agreement of the OP. The remaining rights of the holders of OP units are limited, however, and do not include the ability to replace the general partner or to approve the sale, purchase or refinancing of the OP's assets.
	The Company has investment arrangements with unaffiliated third parties whereby such investors receive an ownership interest in certain of the Company's property-owning subsidiaries and are entitled to receive a proportionate share of the net operating cash flow derived from the subsidiaries' property. Upon disposition of a property subject to non-controlling interest, the investor will receive a proportionate share of the net proceeds from the sale of the property. The investor has no recourse to any other assets of the Company. Due to the nature of the Company's involvement with each of the arrangements described in the table below and the significance of its investment in relation to the investment of the third parties, the Company has determined that it controls each entity in each of these arrangements and, therefore, the entities related to these arrangements are consolidated within the Company's financial statements. A non-controlling interest is recorded for each investors' ownership interest in the property.
	The following table summarizes the activity related to investment arrangements with unaffiliated third parties:
							Distributions
				Net Investment		Non-Controlling Ownership	Three Months Ended September 30,				Nine Months Ended September 30,
	Property Name (Dollar amounts in thousands)		Investment	Amount as of September 30, 2014		Percentage as of September 30, 2014	2014		2013		2014		2013
			Date
	Reliant Rehabilitation - Dallas, TX (2)		Nov. 2011	$	—	—%	$	—	$	41	$	40	$	122
	Odessa Regional MOB - Odessa, TX (1)		Dec. 2011	—		—%	—		—		—		4
	Methodist North MOB - Peoria, IL (1)		Dec. 2011	—		—%	—		—		—		12
	University of Wisconsin Health MOB - Monona, WI (3)		Mar. 2012	—		—%	42		47		134		140
	Total			$	—		$	42	$	88	$	174	$	278
	_________________
	-1	During the year ended December 31, 2013, the Company fully redeemed the third parties' interest in Odessa Regional MOB - Odessa, TX and Methodist North MOB - Peoria, IL for an aggregate of $0.1 million.
	-2	During the three months ended March 31, 2014, Company fully redeemed the third parties' interest in Reliant Rehabilitation - Dallas, TX for an aggregate of $2.0 million.
	-3	During the three months ended September 30, 2014, the Company fully redeemed the third parties' interest in University of Wisconsin Health MOB - Monona, WI for an aggregate of $2.3 million.

Segment_Reporting

Segment Reporting	9 Months Ended
	Sep. 30, 2014
Segment Reporting [Abstract]	'
Segment Reporting	'
	Segment Reporting
	During the three and nine months ended September 30, 2014 and 2013, the Company operated in three reportable business segments for management and internal financial reporting purposes: medical office buildings; triple-net buildings; and seniors housing communities.
	These operating segments are the segments of the Company for which separate financial information are available and for which segment results are evaluated in deciding how to allocate resources and in assessing performance. The medical office buildings primarily consists of medical office buildings leased to healthcare-related tenants under long-term leases, which may require such tenants to pay a pro-rata share of property-related expenses. The seniors housing communities segment primarily consists of investments in assisted living, independent living and memory care facilities located in the United States which the Company operates through engaging independent third-party managers. The triple-net buildings segment primarily consists of investments in hospitals,inpatient rehabilitation facilities and seniors housing communities under long-term leases, under which tenants are responsible to directly pay property-related expenses. The Company evaluates performance of the combined properties in each segment based on net operating income. Net operating income is defined as total revenues less property operating and maintenance expenses. There are no intersegment sales or transfers. The Company uses net operating income to evaluate the operating performance of real estate investments and to make decisions concerning the operation of the properties. The Company believes that net operating income is useful to investors in understanding the value of income-producing real estate. Net income is the GAAP measure that is most directly comparable to net operating income; however, net operating income should not be considered as an alternative to net income as the primary indicator of operating performance as it excludes certain items such as operating fees to affiliates, acquisition and transaction related expenses, general and administrative expenses, depreciation and amortization expense and interest expense. Additionally, net operating income as defined by the Company may not be comparable to net operating income as defined by other REITs or companies.
	For federal income tax purposes, we have elected to be taxed as a REIT beginning with our taxable year ended December 31, 2011. REIT status imposes limitations related to seniors housing communities. Generally, to qualify as a REIT, we cannot directly operate seniors housing communities. However, such facilities may generally be operated by a taxable REIT subsidiary ("TRS") pursuant to a lease with the Company. Therefore, the Company has formed multiple TRS subsidiaries under the OP to operate the seniors housing communities pursuant to contracts with unaffiliated management companies. The Company's TRS entities incurred $0.4 million in federal and state income taxes for the three months ended September 30, 2014 and 2013. The Company's TRS entities incurred $1.0 million and $0.4 million in federal and state income taxes for the nine months ended September 30, 2014 and 2013, respectively. Federal and state income taxes are included in general and administrative expenses on the accompanying consolidated statements of operations and comprehensive loss.
	The following tables reconcile the segment activity to consolidated net income for the three and nine months ended September 30, 2014 and 2013. The segment information for the three and nine months ended September 30, 2013 have been restated to conform to the presentation applicable to the three and nine months ended September 30, 2014.
		Three Months Ended September 30, 2014									Nine months ended September 30, 2014
	(In thousands)	Medical Office Buildings		Triple-Net Buildings		Seniors Housing Communities		Consolidated			Medical Office Buildings		Triple-Net Buildings		Seniors Housing Communities		Consolidated
	Revenues:
	Rental income	$	20,844	$	10,303	$	32,164	$	63,311		$	61,564	$	23,675	$	81,173	$	166,412
	Operating expense reimbursements	4,293		264		—		4,557			12,512		496		—		13,008
	Resident services and fee income	—		—		5,741		5,741			—		—		14,947		14,947
	Total revenues	25,137		10,567		37,905		73,609			74,076		24,171		96,120		194,367
	Property operating and maintenance	5,093		222		26,000		31,315			14,781		609		65,642		81,032
	Net operating income	$	20,044	$	10,345	$	11,905	42,294			$	59,295	$	23,562	$	30,478	113,335
	Operating fees to affiliate							2,711									5,063
	Acquisition and transaction related							10,266									36,144
	Vesting of Class B units for asset management services							—									12,917
	Fair value of listing note							(1,750		)							56,400
	General and administrative							3,175									7,874
	Depreciation and amortization							32,606									93,262
	Interest expense							7,942									20,593
	Income from preferred equity investment and investment securities and interest income							(320		)							(1,115		)
	Loss on sale of investment securities							464									129
	Net loss attributable to non-controlling interests							(679		)							(1,487		)
	Net loss attributable to stockholders							$	(12,121	)							$	(116,445	)
		Three Months Ended September 30, 2013									Nine months ended September 30, 2013
	(In thousands)	Medical Office Buildings		Triple-Net Buildings		Seniors Housing Communities		Consolidated			Medical Office Buildings		Triple-Net Buildings		Seniors Housing Communities		Consolidated
	Revenues:
	Rental income	$	13,026	$	3,047	$	13,212	$	29,285		$	34,053	$	8,853	$	23,251	$	66,157
	Operating expense reimbursements	2,709		150		—		2,859			7,232		290		—		7,522
	Resident services and fee income	—		—		2,003		2,003			—		—		3,083		3,083
	Total revenues	15,735		3,197		15,215		34,147			41,285		9,143		26,334		76,762
	Property operating and maintenance	3,312		160		10,468		13,940			8,577		315		17,684		26,576
	Net operating income	$	12,423	$	3,037	$	4,747	20,207			$	32,708	$	8,828	$	8,650	50,186
	Operating fees to affiliate							—									—
	Acquisition and transaction related							3,107									7,858
	General and administrative							1,429									2,928
	Equity-based compensation							—									—
	Depreciation and amortization							17,140									41,548
	Interest expense							4,350									10,754
	Income from preferred equity investment and investment securities and interest income							(354		)							(609		)
	Net income attributable to non-controlling interests							10									46
	Net loss attributable to stockholders							$	(5,475	)							$	(12,339	)
	The following table reconciles the segment activity to consolidated total assets as of September 30, 2014 and December 31, 2013:
		September 30,		December 31,
	(In thousands)	2014		2013
	Assets
	Investments in real estate:
	Medical office buildings	$	974,669	$	948,122
	Triple-net buildings	404,240		205,367
	Seniors Housing Communities	676,199		423,114
	Total reportable segments, net	2,055,108		1,576,603
	Cash	33,452		103,447
	Restricted cash	3,135		1,381
	Investment securities, at fair value	1,587		14,670
	Preferred equity investment	8,800		—
	Prepaid expenses and other assets	27,725		17,431
	Deferred costs, net	18,530		21,041
	Total assets	$	2,148,337	$	1,734,573

Subsequent_Events

Subsequent Events	9 Months Ended
	Sep. 30, 2014
Subsequent Events [Abstract]	'
Subsequent Events	'
	Subsequent Events
	The Company has evaluated subsequent events through the filing of this Quarterly Report on Form 10-Q, and determined that there have not been any events that have occurred that would require adjustments to disclosures in the consolidated financial statements.

Summary_of_Significant_Account1

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2014
Accounting Policies [Abstract]	'
Reclassifications	'
	Reclassifications
	Certain prior quarter amounts have been reclassified to conform to the current quarter presentation.
Listing Note	'
	Listing Note
	Concurrently with the Listing, the Company caused the OP to issue the Listing Note (see Note 10 — Subordinated Listing Distribution Derivative). Except as provided below, the Listing Note's value will be determined, in part, based on the average market value of the Company's outstanding common stock for the period 180 days to 210 days after the Listing. Until the principal amount of the Listing Note is determined, the Listing Note is treated as a derivative and the Company estimates the contingent consideration using a valuation model and records the fair value of the Listing Note on the consolidated balance sheets. The initial fair value and subsequent changes in fair value are recorded in the consolidated statements of operations and comprehensive loss. Concurrently with the execution of the Merger Agreement, the OP and the SLP entered into an amendment to the Listing Note agreement. Pursuant to the amended Listing Note agreement, contingent upon the occurrence of the Merger at the Effective Time, 5,613,374 OP units will be issued in respect of the termination of the Listing Note.
Multi-Year Outperformance Agreement	'
	Multi-Year Outperformance Agreement
	On April 7, 2014 (the "OPP Effective Date") in connection with the Listing, the Company entered into the OPP with the OP and the Advisor. Because the Advisor can terminate at any time and receive the value of the award at the next anniversary date, the estimated value of the award as of the first anniversary was expensed on the OPP Effective Date and the estimated value of the award on the second and third anniversaries is being amortized over the first year and first two years of the OPP, respectively, and adjusted to reflect the probability of the closing of the Merger. The award and related expense is adjusted each reporting period for changes in the estimated value. Concurrently with the execution of the Merger Agreement, the Company, the OP and the Advisor entered into an agreement terminating the OPP, pursuant to which the OPP will terminate without payment to the Advisor, contingent on the closing of the Merger (see Note 17 — Equity-Based Compensation).
Tender Offer	'
	Tender Offer
	The Company recorded the excess of the cost of the tendered shares over its par value to additional paid-in capital.
Recently Issued Accounting Pronouncements	'
	Recently Issued Accounting Pronouncements
	In February 2013, the Financial Accounting Standards Board ("FASB") issued new accounting guidance clarifying the accounting and disclosure requirements for obligations resulting from joint and several liability arrangements for which the total amount under the arrangement is fixed at the reporting date. The new guidance was effective for fiscal years, and interim periods within those fiscal years, beginning on or after December 15, 2013. The adoption of this guidance did not have a material impact on the Company's consolidated financial position, results of operations or cash flows.
	In April 2014, the FASB amended the requirements for reporting discontinued operations. Under the revised guidance, in addition to other disclosure requirements, a disposal of a component of an entity or a group of components of an entity is required to be reported in discontinued operations if the disposal represents a strategic shift that has (or will have) a major effect on an entity's operations and financial results when the component or group of components meets the criteria to be classified as held for sale, disposed of by sale or other than by sale. The Company has adopted the provisions of this guidance effective January 1, 2014, and has applied the provisions prospectively. The adoption of this guidance did not have a material impact on the Company's consolidated financial position, results of operations or cash flows.
	In May 2014, the FASB issued revised guidance relating to revenue recognition. Under the revised guidance, an entity is required to recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The revised guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2016. Early adoption is not permitted under GAAP. The revised guidance allows entities to apply the full retrospective or modified retrospective transition method upon adoption. The Company has not yet selected a transition method and is currently evaluating the impact of the new guidance.

Real_Estate_Investments_Tables

Real Estate Investments (Tables)	9 Months Ended
	Sep. 30, 2014
Real Estate [Abstract]	'
Assets and Liabilities Assumed	'
	The following table presents the allocation of the assets acquired and liabilities assumed during the nine months ended September 30, 2014 and 2013:
			Nine Months Ended September 30,
	(Dollar amounts in thousands)		2014			2013
	Real estate investments, at cost:
	Land		$	41,245		$	64,357
	Buildings, fixtures and improvements		461,095			595,820
	Construction in progress		8,561			4,819
	Total tangible assets		510,901			664,996
	Acquired intangibles:
	In-place leases		59,238			78,020
	Above-market lease assets		—			5,371
	Below-market lease liabilities		—			(4,272		)
	Total assets acquired, net		570,139			744,115
	Preferred equity investment (see Note 5 — Preferred Equity Investment)		8,800			—
	Deposits for real estate		(3,590		)	—
	Mortgage notes payable assumed or used to acquire real estate investments		(45,530		)	(39,192		)
	Premiums on mortgages assumed		(1,879		)	(692		)
	Other liabilities assumed		(529		)	(1,517		)
	Cash paid for acquired real estate and preferred equity investments		$	527,411		$	702,714
	Number of properties purchased		38			53
Proforma Revenue and Losses, Disclosure	'
	The following table presents unaudited pro forma information as if the acquisitions during the nine months ended September 30, 2014, had been consummated on January 1, 2013. Additionally, the unaudited pro forma net loss attributable to stockholders was adjusted to exclude acquisition related expense of $8.2 million from the nine months ended September 30, 2014.
			Nine Months Ended September 30,
	(In thousands)		2014			2013
	Pro forma revenues		$	221,631		$	139,050
	Pro forma net loss attributable to stockholders		$	(107,176	)	$	(7,975	)
Schedule of Future Minimum Rental Payments for Operating Leases	'
	The following table presents future minimum base rental cash payments due to the Company over the next five years and thereafter. These amounts exclude contingent rent payments, as applicable, that may be collected from certain tenants based on provisions related to sales thresholds and increases in annual rent based on exceeding certain economic indexes among other items.
	(In thousands)		Future Minimum
			Base Rent Payments
	October 1, 2014 — December 31, 2014		$	28,642
	2015		116,563
	2016		117,860
	2017		117,183
	2018		112,136
	Thereafter		810,444
			$	1,302,828
Schedule of Annualized Rental Income by Major Tenants	'
	The following table lists the tenants (including for this purpose, all affiliates of such tenants) whose annualized rental income on a straight-line basis represented approximately 10% or greater of total annualized rental income for all portfolio properties on a straight-line basis as of September 30, 2014 and 2013:
			September 30,
	Tenant		2014		2013
	UnitedHealth Group Incorporated		*		10.70%
	____________________________
	*	Tenant's annualized rental income on a straight-line basis was not greater than 10% of total annualized rental income for all tenants as of the period specified.
Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas	'
	The following table lists the states where the Company has concentrations of properties where annualized rental income on a straight-line basis represents approximately 10% or more of consolidated annualized rental income on a straight-line basis for all properties as of September 30, 2014 and 2013:
			September 30,
	State		2014		2013
	Florida		*		11.40%
	Georgia		12.80%		16.60%
	Oregon		*		18.40%
	Texas		11.80%		*
	____________________________
	*	State's annualized rental income on a straight-line basis was not 10% or more of total annualized rental income for all portfolio properties as of the date specified.

Investment_Securities_Tables

Investment Securities (Tables)	9 Months Ended
	Sep. 30, 2014
Investment Securities [Abstract]	'
Schedule of Available-for-sale Securities Reconciliation	'
	The following table details the unrealized gains and losses on investment securities as of September 30, 2014 and December 31, 2013:
	(In thousands)	Cost		Gross Unrealized Gains		Gross Unrealized Losses			Fair Value
	30-Sep-14
	Investment securities	$	1,573	$	14	$	—		$	1,587
	31-Dec-13
	Investment securities	$	17,580	$	202	$	(3,112	)	$	14,670

Mortgage_Notes_Payable_Tables

Mortgage Notes Payable (Tables)	9 Months Ended
	Sep. 30, 2014
Debt Disclosure [Abstract]	'
Schedule of Mortgage Notes Payable	'
	The Company's mortgage notes payable as of September 30, 2014 and December 31, 2013 consist of the following:
					Outstanding Loan Amount as of				Effective Interest Rate
	Portfolio		Encumbered Properties		September 30, 2014		December 31, 2013					Interest Rate	Maturity
					(In thousands)		(In thousands)
	Texarkana ASC - Texarkana, TX		1		$	2,108	$	2,143	5.58	%		Fixed	Jun. 2016
	Carson Tahoe Specialty Medical Center - Carson City, NV (1)		3		21,751		21,751		5.08	%		Fixed	Sep. 2017
	Durango Medical Plaza - Las Vegas, NV (1)		1		17,172		17,172		5.08	%		Fixed	Sep. 2017
	CareMeridian Rehabilitation - Phoenix, AZ (1)		1		6,936		6,936		5.08	%		Fixed	Sep. 2017
	Reliant Rehabilitation - Dallas, TX (1)		1		24,850		24,850		5.15	%		Fixed	Sep. 2017
	Select Rehabilitation - San Antonio, TX (1)		1		12,714		12,714		5.15	%		Fixed	Sep. 2017
	Spring Creek Medical Plaza - Tomball, TX (1)		1		7,477		7,477		5.15	%		Fixed	Sep. 2017
	Odessa Regional MOB - Odessa, TX		1		4,047		4,047		4.09	%	(2)	Fixed	Dec. 2016
	Methodist North MOB - Peoria, IL		1		13,544		13,544		3.99	%	(2)	Fixed	Dec. 2016
	University of Wisconsin Health MOB - Monona, WI		1		5,039		5,039		4	%		Fixed	Apr. 2017
	Reliant Rehabilitation - Houston, TX (1)		1		13,437		13,437		4.98	%		Fixed	Sep. 2017
	Village Healthcare Center - Santa Ana (1)		1		1,906		1,906		4.98	%		Fixed	Sep. 2017
	Sisters of Mercy Building - Springfield, MO		1		5,500		5,500		4.11	%		Fixed	Sep. 2017
	East Pointe Medical Plaza - Lehigh Acres, FL		1		5,260		5,260		4.11	%		Fixed	Sep. 2017
	Unitron Hearing Building - Plymouth, MN		1		4,000		4,000		4.11	%		Fixed	Sep. 2017
	Carson Tahoe MOB West - Carson City, NV		1		4,675		4,675		3.88	%	(2)	Fixed	Jun. 2017
	Aurora Health Care Portfolio		3		49,600		49,600		5.6	%		Fixed	Jan. 2017
	Princeton Village - Clackamas, OR		1		3,044		3,114		7.48	%		Fixed	Jan. 2031
	Pelican Pointe - Klamath Falls, OR		1		12,318		12,460		5.16	%		Fixed	Apr. 2022
	Fayette MOB - Fayetteville, GA		1		6,859		6,986		5.18	%		Fixed	Sep. 2015
	Garden House - Anderson, SC		1		8,048		8,149		4.86	%		Fixed	Dec. 2018
	Benton House - Covington, GA		1		8,030		8,121		5.26	%		Fixed	May-19
	Arbor Terrace - Asheville, SC		1		9,402		9,497		5.58	%		Fixed	Feb. 2018
	Arbor Terrace - Decatur, GA		1		10,860		10,970		5.57	%		Fixed	Jan. 2018
	Casa de Santa Fe - Rocklin, CA		1		20,491		—		4.71	%		Fixed	Oct. 2021
	Bay Medical Plaza - Lynn Haven, FL		1		9,579		—		6.61	%		Fixed	Aug. 2017
	Bay Medical Center - Panama City, FL		1		9,321		—		6.61	%		Fixed	Aug. 2017
	Legacy Heart Center - Plano, TX		1		5,863		—		5.76	%		Fixed	Oct. 2015
	Total		32		$	303,831	$	259,348	5.17	%	(3)
	_____________________________________
	-1	These mortgages, aggregating $106.2 million, represent the first, second and third tranches of a multi-tranche mortgage loan agreement to provide funding for a portfolio of eight properties. The mortgages for each of the properties are cross-collateralized with one another and in the event that the Company defaults on one of the mortgages, the lender may look to the other properties as collateral. During the three months ended September 30, 2014, the maturity date on these mortgages was extended to September 2017 from September 2015.
	-2	Fixed as a result of entering into a swap agreement.
	-3	Calculated on a weighted average basis for all mortgages outstanding as of September 30, 2014.
Schedule of Aggregate Principal Payments of Mortgages	'
	The following table summarizes the scheduled aggregate principal payments on mortgage notes payable for the five years subsequent to September 30, 2014:
	(In thousands)		Future Principal
			Payments
	October 1, 2014 — December 31, 2014		$	393
	2015		13,937
	2016		20,936
	2017		200,596
	2018		27,778
	Thereafter		40,191
			$	303,831

Fair_Value_of_Financial_Instru1

Fair Value of Financial Instruments (Tables)	9 Months Ended
	Sep. 30, 2014
Fair Value Disclosures [Abstract]	'
Schedule of fair value, liabilities measured on recurring basis	'
	The following table presents information about the Company's assets and liabilities (including derivatives that are presented net) measured at fair value on a recurring basis as of September 30, 2014 and December 31, 2013, aggregated by the level in the fair value hierarchy within which those instruments fall:
	(In thousands)	Quoted Prices in Active Markets				Significant Other Observable Inputs				Significant Unobservable Inputs				Total
		Level 1				Level 2				Level 3
	September 30, 2014
	Interest rate swaps	$	—			$	(233	)		$	—			$	(233	)
	Investment securities	$	1,587			$	—			$	—			$	1,587
	OPP (1)	$	—			$	—			$	(1,285	)		$	(1,285	)
	Listing Note	$	—			$	—			$	(56,400	)		$	(56,400	)
	December 31, 2013
	Interest rate swaps	$	—			$	(333	)		$	—			$	(333	)
	Investment securities	$	14,670			$	—			$	—			$	14,670
	__________________
	(1) The amount presented represents the fair value of all LTIP units issued under the OPP, of which $0.2 million and $0.7 million have been recorded in general and administrative expense on the consolidated statement of operations and comprehensive loss for the three and nine months ended September 30, 2014, respectively, and are presented as a liability on the consolidated balance sheet in accounts payable and accrued expenses.
Liabilities measured on recurring basis, unobservable input reconciliation	'
	The following is a reconciliation of the beginning and ending balance for the changes in instruments with Level 3 inputs in the fair value hierarchy for the nine months ended September 30, 2014:
	(In thousands)	OPP				Listing Note
	Beginning balance as of December 31, 2013	$	—			$	—
	Fair value at issuance	33,200				27,400
	Fair value adjustments	(31,915		)		29,000
	Ending balance as of September 30, 2014	$	1,285			$	56,400
Recurring and nonrecurring, valuation techniques	'
	The following table provides quantitative information about the significant Level 3 inputs used:
	Financial Instrument	Fair Value at September 30, 2014				Principal Valuation Technique		Unobservable Inputs		Input Value
		(In thousands)
	Listing Note	$	56,400			Monte Carlo Simulation		Expected volatility		20.00%
								Merger Probability		95.00%
	OPP	$	1,285			Monte Carlo Simulation		Expected volatility		23.00%
								Merger Probability		95.00%
Fair Value, by balance sheet grouping	'
	The fair values of the Company's remaining financial instruments that are not reported at fair value on the consolidated balance sheets are reported below:
				Carrying Amount at				Fair Value at				Carrying Amount at				Fair Value at
	(In thousands)	Level		September 30, 2014				September 30, 2014				December 31, 2013				December 31, 2013
	Mortgage notes payable and premiums, net (1)	3		$	307,443			$	316,664			$	262,117			$	266,242
	Credit facility	3		$	619,400			$	619,400			$	—			$	—
	Preferred equity investment	3		$	8,800			$	8,800			$	—			$	—
	________________
	(1) Carrying values include $303.8 million and $259.3 million mortgage notes payable and $3.6 million and $2.8 million net mortgage premiums as of September 30, 2014 and December 31, 2013, respectively.

Interest_Rate_Derivatives_and_1

Interest Rate Derivatives and Hedging Activities (Tables)	9 Months Ended
	Sep. 30, 2014
Derivative Instruments and Hedging Activities Disclosure [Abstract]	'
Schedule of Interest Rate Derivatives	'
	As of September 30, 2014 and December 31, 2013, the Company had the following outstanding interest rate derivatives that were designated as cash flow hedges of interest rate risk:
		September 30, 2014						December 31, 2013
	Interest Rate Derivative	Number of		Notional Amount				Number of		Notional Amount
		Instruments						Instruments
				(In thousands)						(In thousands)
	Interest rate swaps	3		$	22,266			3		$	22,266
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value	'
	The table below presents the fair value of the Company's derivative financial instruments as well as their classification on the consolidated balance sheets as of September 30, 2014 and December 31, 2013:
	(In thousands)	Balance Sheet Location		September 30, 2014				December 31, 2013
	Derivatives designated as hedging instruments:
	Interest rate swaps	Derivatives, at fair value		$	(233	)		$	(333	)
Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance	'
	The table below details the location in the financial statements of the gain or loss recognized on interest rate derivatives designated as cash flow hedges for the three and nine months ended September 30, 2014 and 2013:
		Three Months Ended September 30,								Nine Months Ended September 30,
	(In thousands)	2014				2013				2014			2013
	Amount of income (loss) recognized in accumulated other comprehensive loss from interest rate derivatives (effective portion)	$	42			$	(139	)		$	(92	)	$	83
	Amount of loss reclassified from accumulated other comprehensive loss into income as interest expense (effective portion)	$	(65	)		$	(62	)		$	(192	)	$	(183	)
	Amount of gain (loss) recognized in income on derivative instruments (ineffective portion and amount excluded from effectiveness testing)	$	—			$	—			$	—		$	—
Offsetting Liabilities	'
	The table below presents a gross presentation, the effects of offsetting, and a net presentation of the Company's interest rate derivatives as of September 30, 2014 and December 31, 2013. The net amounts of derivative assets or liabilities can be reconciled to the tabular disclosure of fair value. The table below provides the location that the fair value of derivative assets and liabilities are presented on the accompanying consolidated balance sheets:
													Gross Amounts Not Offset on the Balance Sheet
	Derivatives (In thousands)	Gross Amounts of Recognized Liabilities				Gross Amounts Offset on the Balance Sheet				Net Amounts of Liabilities presented on the Balance Sheet			Financial Instruments			Cash Collateral Posted		Net Amount
	September 30, 2014	$	(233	)		$	—			$	(233	)	$	—		$	—	$	(233	)
	December 31, 2013	$	(333	)		$	—			$	(333	)	$	—		$	—	$	(333	)

Common_Stock_Tables

Common Stock (Tables)	9 Months Ended
	Sep. 30, 2014
Stockholders' Equity Note [Abstract]	'
Schedule of Treasury Stock by Class	'
	On March 30, 2014, the board of directors approved the termination of the Company's Share Repurchase Program ("SRP"). The Company processed all of the requests received under the SRP for the first quarter of 2014 and did not and will not process further requests. The following table reflects the cumulative number of shares repurchased under the Company's SRP through the end of the program on March 30, 2014:
		Number of Requests	Number of Shares Repurchased	Average Price per Share
	Cumulative repurchase requests as of December 31, 2013	122	386,968	$	9.77
	Requests made in 2014	22	69,476	9.85
	Cumulative repurchase requests as of the end of the program	144	456,444	$	9.79

Commitments_and_Contingencies_

Commitments and Contingencies (Tables)	9 Months Ended
	Sep. 30, 2014
Commitments and Contingencies Disclosure [Abstract]	'
Schedule of Future Minimum Rental Payments for Operating Leases	'
	The following table reflects the minimum base cash rental payments due from the Company over the next five years and thereafter under these arrangements.  These amounts exclude contingent rent payments, as applicable, that may be payable based on provisions related to increases in annual rent based on exceeding certain economic indexes among other items.
	(In thousands)	Future Minimum
		Lease Payments
	October 1, 2014 — December 31, 2014	$	167
	2015	627
	2016	634
	2017	641
	2018	664
	Thereafter	23,553
		$	26,286

Related_Party_Transactions_and1

Related Party Transactions and Arrangements (Tables)	9 Months Ended
	Sep. 30, 2014
Related Party Transactions [Abstract]	'
Schedule of Selling Commissions and Dealer Manager Fees Payable to Affiliate	'
	The following table details total selling commissions and dealer manager fees incurred and receivable from the Dealer Manager as of and for the periods presented:
		Three Months Ended					Nine Months Ended				Receivable (1) as of
		September 30,					September 30,				September 30,		December 31,
	(In thousands)	2014		2013			2014		2013		2014		2013
	Total commissions and fees incurred from the Dealer Manager	$	—	$	(48	)	$	—	$	117,377	$	—	$	(18	)
	_____________________
	(1) Includes reimbursements received for selling commissions and dealer manager fees as a result of share purchase cancellations related to common stock sales prior to the close of the IPO
Schedule Of Offering Costs Reimbursements to Related Party	'
	The following table details offering costs and reimbursements incurred from and payable to the Advisor and Dealer Manager as of and for the periods presented:
		Three Months Ended					Nine Months Ended				Payable as of
		September 30,					September 30,				September 30,		December 31,
	(In thousands)	2014		2013			2014		2013		2014		2013
	Fees and expense reimbursements incurred from the Advisor and Dealer Manager	$	—	$	—		$	—	$	1,901	$	—	$	—
Schedule of Amount Contractually Due and Forgiven in Connection With Operation Related Services	'
	The following table details amounts incurred, forgiven and payable to related parties in connection with the Company's operations-related services described above as of and for the periods presented:
		Three Months Ended September 30,									Nine Months Ended September 30,									Payable as of
		2014					2013				2014					2013				September 30,		December 31,
	(In thousands)	Incurred		Forgiven			Incurred		Forgiven		Incurred		Forgiven			Incurred		Forgiven		2014		2013
	One-time fees and reimbursements:
	Acquisition fees and related cost reimbursements	$	1,151	$	—		$	697	$	—	$	5,684	$	—		$	3,577	$	—	$	—	$	—
	Transaction fee	—		—			306		—		—		—			306		—		—		—
	Financing coordination fees	—		—			7,784		—		361		—			7,942		—		—		—
	Other expense reimbursements	—		—			—		—		—		—			19		—		—		—
	Ongoing fees:
	Asset management services (1)	2,711		—			—		—		5,063		—			—		—		—		—
	Property management and leasing fees	—		793			—		370		—		2,105			—		861		—		—
	Transfer agent and other professional fees	350		—			621		—		1,547		—			847		—		213		235
	Strategic advisory fees	—		—			—		—		—		—			920		—		—		—
	Dividends on Class B Units	—		—			63		—		151		—			117		—		—		—
	Total related party operation fees and reimbursements	$	4,212	$	793		$	9,471	$	370	$	12,806	$	2,105		$	13,728	$	861	$	213	$	235
	________________
	(1) Prior to the Listing, the Company caused the OP to issue the Advisor restricted performance based Class B units for asset management services, which vested with the Listing. Amounts reflected in the table reflect asset management services following the Listing as described above.

EquityBased_Compensation_Table

Equity-Based Compensation (Tables)	9 Months Ended
	Sep. 30, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'
Schedule of Share-based Compensation, Activity	'
	The following table reflects restricted share award activity to the Company's board of directors for the nine months ended September 30, 2014:
		Number of Restricted Shares		Weighted-Average Issue Price
	Unvested, December 31, 2013	18,000		$	9.23
	Granted	225,905		10.45
	Vested (1)	(18,000	)	9.23
	Unvested, September 30, 2014	225,905		$	10.45
	______________________
	(1) Previously granted unvested restricted stock outstanding vested as of the Listing.
Schedule of Share-based Compensation Arrangement by Share-based Payment Award, Performance-Based Units, Performance Schedule	'
	If the Merger is not completed, the Advisor may be eligible to earn a number of LTIP units with a value equal to a portion of the OPP Cap upon the first, second and third anniversaries of the OPP Effective Date based on the Company's achievement of certain levels of total return to its stockholders ("Total Return"), including both share price appreciation and common stock dividends, as measured against a peer group of companies, as set forth below, for the three-year performance period commencing on the OPP Effective Date (the "Three-Year Period"); each 12-month period during the Three-Year Period (each, a "One-Year Period"); and the initial 24-month period of the Three-Year Period (the "Two-Year Period"), as follows:
				Performance Period		Annual Period	Interim Period
	Absolute Component: 4% of any excess Total Return attained above an absolute hurdle measured from the beginning of such period:			21%		7%	14%
	Relative Component: 4% of any excess Total Return attained above the Total Return for the performance period of the Peer Group*, subject to a ratable sliding scale factor as follows based on achievement of cumulative Total Return measured from the beginning of such period:
		•	100% will be earned if cumulative Total Return achieved is at least:	18%		6%	12%
		•	50% will be earned if cumulative Total Return achieved is:	—%		—%	—%
		•	0% will be earned if cumulative Total Return achieved is less than:	—%		—%	—%
		•	a percentage from 50% to 100% calculated by linear interpolation will be earned if the cumulative Total Return achieved is between:	0% - 18%		0% - 6%	0%- 12%
	____________________
	*The "Peer Group" is comprised of the companies in the SNL US REIT Healthcare Index.

Net_Loss_Per_Share_Tables

Net Loss Per Share (Tables)	9 Months Ended
	Sep. 30, 2014
Earnings Per Share [Abstract]	'
Schedule of Earnings Per Share, Basic and Diluted	'
	The following is a summary of the basic and diluted net loss per share computation for the three and nine months ended September 30, 2014 and 2013:
		Three Months Ended September 30,							Nine Months Ended September 30,
		2014				2013			2014			2013
	Net loss attributable to stockholders (in thousands)	$	(12,121	)		$	(5,475	)	$	(116,445	)	$	(12,339	)
	Basic and diluted weighted average shares outstanding	169,090,342				178,231,121			175,234,437			142,163,876
	Basic and diluted net loss per share attributable to stockholders	$	(0.07	)		$	(0.03	)	$	(0.66	)	$	(0.09	)
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	'
	The Company had the following common share equivalents as of September 30, 2014 and 2013, which were excluded from the calculation of diluted loss per share attributable to stockholders as the effect would have been antidilutive:
		September 30,
		2014			2013
	Unvested restricted stock	225,905			22,200
	OP units	1,443,897			202
	LTIP units	9,219,108			—
	Class B units	—			441,735
	Total common stock equivalents	10,888,910			464,137

NonControlling_Interests_Table

Non-Controlling Interests (Tables)	9 Months Ended
	Sep. 30, 2014
Noncontrolling Interest [Abstract]	'
Schedule of Noncontrolling Interests	'
	The following table summarizes the activity related to investment arrangements with unaffiliated third parties:
							Distributions
				Net Investment		Non-Controlling Ownership	Three Months Ended September 30,				Nine Months Ended September 30,
	Property Name (Dollar amounts in thousands)		Investment	Amount as of September 30, 2014		Percentage as of September 30, 2014	2014		2013		2014		2013
			Date
	Reliant Rehabilitation - Dallas, TX (2)		Nov. 2011	$	—	—%	$	—	$	41	$	40	$	122
	Odessa Regional MOB - Odessa, TX (1)		Dec. 2011	—		—%	—		—		—		4
	Methodist North MOB - Peoria, IL (1)		Dec. 2011	—		—%	—		—		—		12
	University of Wisconsin Health MOB - Monona, WI (3)		Mar. 2012	—		—%	42		47		134		140
	Total			$	—		$	42	$	88	$	174	$	278
	_________________
	-1	During the year ended December 31, 2013, the Company fully redeemed the third parties' interest in Odessa Regional MOB - Odessa, TX and Methodist North MOB - Peoria, IL for an aggregate of $0.1 million.
	-2	During the three months ended March 31, 2014, Company fully redeemed the third parties' interest in Reliant Rehabilitation - Dallas, TX for an aggregate of $2.0 million.
	-3	During the three months ended September 30, 2014, the Company fully redeemed the third parties' interest in University of Wisconsin Health MOB - Monona, WI for an aggregate of $2.3 million.

Segment_Reporting_Tables

Segment Reporting (Tables)	9 Months Ended
	Sep. 30, 2014
Segment Reporting [Abstract]	'
Schedule of Segment Reporting Information, by Segment	'
	The following tables reconcile the segment activity to consolidated net income for the three and nine months ended September 30, 2014 and 2013. The segment information for the three and nine months ended September 30, 2013 have been restated to conform to the presentation applicable to the three and nine months ended September 30, 2014.
		Three Months Ended September 30, 2014									Nine months ended September 30, 2014
	(In thousands)	Medical Office Buildings		Triple-Net Buildings		Seniors Housing Communities		Consolidated			Medical Office Buildings		Triple-Net Buildings		Seniors Housing Communities		Consolidated
	Revenues:
	Rental income	$	20,844	$	10,303	$	32,164	$	63,311		$	61,564	$	23,675	$	81,173	$	166,412
	Operating expense reimbursements	4,293		264		—		4,557			12,512		496		—		13,008
	Resident services and fee income	—		—		5,741		5,741			—		—		14,947		14,947
	Total revenues	25,137		10,567		37,905		73,609			74,076		24,171		96,120		194,367
	Property operating and maintenance	5,093		222		26,000		31,315			14,781		609		65,642		81,032
	Net operating income	$	20,044	$	10,345	$	11,905	42,294			$	59,295	$	23,562	$	30,478	113,335
	Operating fees to affiliate							2,711									5,063
	Acquisition and transaction related							10,266									36,144
	Vesting of Class B units for asset management services							—									12,917
	Fair value of listing note							(1,750		)							56,400
	General and administrative							3,175									7,874
	Depreciation and amortization							32,606									93,262
	Interest expense							7,942									20,593
	Income from preferred equity investment and investment securities and interest income							(320		)							(1,115		)
	Loss on sale of investment securities							464									129
	Net loss attributable to non-controlling interests							(679		)							(1,487		)
	Net loss attributable to stockholders							$	(12,121	)							$	(116,445	)
		Three Months Ended September 30, 2013									Nine months ended September 30, 2013
	(In thousands)	Medical Office Buildings		Triple-Net Buildings		Seniors Housing Communities		Consolidated			Medical Office Buildings		Triple-Net Buildings		Seniors Housing Communities		Consolidated
	Revenues:
	Rental income	$	13,026	$	3,047	$	13,212	$	29,285		$	34,053	$	8,853	$	23,251	$	66,157
	Operating expense reimbursements	2,709		150		—		2,859			7,232		290		—		7,522
	Resident services and fee income	—		—		2,003		2,003			—		—		3,083		3,083
	Total revenues	15,735		3,197		15,215		34,147			41,285		9,143		26,334		76,762
	Property operating and maintenance	3,312		160		10,468		13,940			8,577		315		17,684		26,576
	Net operating income	$	12,423	$	3,037	$	4,747	20,207			$	32,708	$	8,828	$	8,650	50,186
	Operating fees to affiliate							—									—
	Acquisition and transaction related							3,107									7,858
	General and administrative							1,429									2,928
	Equity-based compensation							—									—
	Depreciation and amortization							17,140									41,548
	Interest expense							4,350									10,754
	Income from preferred equity investment and investment securities and interest income							(354		)							(609		)
	Net income attributable to non-controlling interests							10									46
	Net loss attributable to stockholders							$	(5,475	)							$	(12,339	)
	The following table reconciles the segment activity to consolidated total assets as of September 30, 2014 and December 31, 2013:
		September 30,		December 31,
	(In thousands)	2014		2013
	Assets
	Investments in real estate:
	Medical office buildings	$	974,669	$	948,122
	Triple-net buildings	404,240		205,367
	Seniors Housing Communities	676,199		423,114
	Total reportable segments, net	2,055,108		1,576,603
	Cash	33,452		103,447
	Restricted cash	3,135		1,381
	Investment securities, at fair value	1,587		14,670
	Preferred equity investment	8,800		—
	Prepaid expenses and other assets	27,725		17,431
	Deferred costs, net	18,530		21,041
	Total assets	$	2,148,337	$	1,734,573

Organization_Details

Organization (Details) (USD $)	9 Months Ended					0 Months Ended
In Thousands, except Share data, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Dec. 31, 2013	Feb. 28, 2011	Feb. 28, 2011	2-May-14	Apr. 07, 2014	Apr. 07, 2014
	property				Common Stock	Tender Offer	Tender Offer	Tender Offer
	state
	sqft
Operations [Line Items]	'	'	'	'	'	'	'	'
Number of properties owned (properties)	153	'	'	'	'	'	'	'
Number of states in which entity operates (states)	31	'	'	'	'	'	'	'
Rentable space (sqft)	7,900,000	'	'	'	'	'	'	'
Shares available in IPO (in shares)	'	'	'	'	150,000,000	'	'	'
Common stock, par value (in dollars per share)	$0.01	'	$0.01	$0.01	'	'	'	'
Shares issued or available for issuance under initial public offering (in dollars per share)	'	'	'	'	$10	'	'	'
Shares authorized to be repurchased (in shares)	'	'	'	'	'	'	'	13,600,000
Treasury stock price (in dollars per share)	'	'	'	'	'	$11	$11	'
Share repurchased (in shares)	'	'	'	'	'	13,600,000	'	'
Common stock repurchases	$152,144	$1,764	'	'	'	$150,100	'	'

Merger_Agreement_Details

Merger Agreement (Details) (USD $)

3 Months Ended

9 Months Ended

0 Months Ended

3 Months Ended

9 Months Ended

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Dec. 31, 2013

Feb. 28, 2011

Jun. 01, 2014

Sep. 30, 2014

Sep. 30, 2014

Jun. 01, 2014

Jun. 01, 2014

Sep. 30, 2014

Ventas, Inc

Ventas, Inc

Ventas, Inc

Ventas, Inc

Ventas, Inc

Ventas, Inc

Ventas Common Stock

Operating Partnership Unit

Business Acquisition [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

Common stock, par value (in dollars per share)

$0.01

'

$0.01

'

$0.01

$0.01

'

'

'

$0.01

$0.25

'

Redemption price per share (dollars per share)

'

'

'

'

'

'

'

'

'

$11.33

'

'

Maximum percent of shares available for cash redemption (percent)

'

'

'

'

'

'

10.00%

'

'

'

'

'

Conversion ratio (in shares)

'

'

'

'

'

'

0.1688

'

'

'

'

'

OP units to be issued in respect of the termination of the Listing Note Agreement (in units)

'

'

'

'

'

'

'

'

'

'

'

5,613,374

Maximum expense reimbursement

'

'

'

'

'

'

'

'

'

$10,000,000

'

'

Maximum termination fee reimbursement

'

'

'

'

'

'

'

'

'

55,000,000

'

'

Maximum transaction related costs

'

'

'

'

'

'

'

'

'

23,600,000

'

'

Acquisition and transaction related

$10,266,000

$3,107,000

$36,144,000

$7,858,000

'

'

'

$7,800,000

$13,100,000

'

'

'

Summary_of_Significant_Account2

Summary of Significant Accounting Policies (Details)	9 Months Ended
	Sep. 30, 2014
Minimum	'
Business Acquisition [Line Items]	'
Number of days after listing the value of the units are determined	'180 days
Maximum	'
Business Acquisition [Line Items]	'
Number of days after listing the value of the units are determined	'210 days
Operating Partnership Unit | Ventas, Inc	'
Business Acquisition [Line Items]	'
OP units to be issued in respect of the termination of the Listing Note Agreement (in units)	5,613,374

Real_Estate_Investments_Schedu

Real Estate Investments (Schedule of Assets and Liabilities Assumed) (Details) (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013
	property	property
Real estate investments, at cost:	'	'
Land	$41,245	$64,357
Buildings, fixtures and improvements	461,095	595,820
Construction in progress	8,561	4,819
Total tangible assets	510,901	664,996
Total assets acquired, net	570,139	744,115
Preferred equity investment (see Note 5 b Preferred Equity Investment)	8,800	0
Deposits for real estate	-3,590	0
Mortgage notes payable assumed or used to acquire real estate investments	-45,530	-39,192
Premiums on mortgages assumed	-1,879	-692
Other liabilities assumed	-529	-1,517
Cash paid for acquired real estate and preferred equity investments	527,411	702,714
Number of Properties, Acquired	38	53
In-place leases	'	'
Real estate investments, at cost:	'	'
Acquired intangibles:	59,238	78,020
Above-market lease assets	'	'
Real estate investments, at cost:	'	'
Acquired intangibles:	0	5,371
Below-market lease liabilities	'	'
Real estate investments, at cost:	'	'
Acquired intangibles:	$0	($4,272)

Real_Estate_Investments_Schedu1

Real Estate Investments (Schedule of Real Estate Properties) (Details) (USD $)	9 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2014
Real Estate [Abstract]	'
Transaction expenses	$8.20

Real_Estate_Investments_Schedu2

Real Estate Investments (Schedule of Pro Forma Revenues and Losses) (Details) (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013
Real Estate [Abstract]	'	'
Pro forma revenues	$221,631	$139,050
Pro forma net loss attributable to stockholders	($107,176)	($7,975)

Real_Estate_Investments_Schedu3

Real Estate Investments (Schedule of Future Minimum Rental Payments for Operating Leases) (Details) (USD $)	Sep. 30, 2014
In Thousands, unless otherwise specified
Real Estate [Abstract]	'
October 1, 2014 b December 31, 2014	$28,642
2015	116,563
2016	117,860
2017	117,183
2018	112,136
Thereafter	810,444
Future minimum payments receivable	$1,302,828

Real_Estate_Investments_Schedu4

Real Estate Investments (Schedule of Revenue from External Customers and Long-Lived Assets, by Customer) (Details) (UnitedHealth Group Incorporated)	9 Months Ended
	Sep. 30, 2013
UnitedHealth Group Incorporated	'
Revenue from External Customer [Line Items]	'
Concentration Risk, Percentage	10.70%

Real_Estate_Investments_Schedu5

Real Estate Investments (Schedule of Revenue from External Customers and Long-Lived Assets, by Geographic Areas) (Details)	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Florida	'	'
Revenues from External Customers and Long-Lived Assets [Line Items]	'	'
Concentration percentage	'	11.40%
Georgia	'	'
Revenues from External Customers and Long-Lived Assets [Line Items]	'	'
Concentration percentage	12.80%	16.60%
Oregon	'	'
Revenues from External Customers and Long-Lived Assets [Line Items]	'	'
Concentration percentage	'	18.40%
Texas	'	'
Revenues from External Customers and Long-Lived Assets [Line Items]	'	'
Concentration percentage	11.80%	'

Preferred_Equity_Investment_De

Preferred Equity Investment (Details) (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Dec. 31, 2013
Preferred Equity Investment [Abstract]	'	'
Preferred equity investment	$8,800	$0
Duration of preferred equity investment	'10 years	'
Preferred equity investment current pay rate	0.50%	'
Preferred equity investment current accrual rate	10.00%	'

Investment_Securities_Details

Investment Securities (Details) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013	Dec. 31, 2013
Investment Securities [Abstract]	'	'	'	'	'
Cost	$1,573,000	'	$1,573,000	'	$17,580,000
Gross Unrealized Gains	14,000	'	14,000	'	202,000
Gross Unrealized Losses	0	'	0	'	-3,112,000
Fair Value	1,587,000	'	1,587,000	'	14,670,000
Cost of security sold	19,000,000	'	19,000,000	'	'
Proceeds from sale of short-term investments	'	'	18,900,000	'	'
Loss on sale of investment securities	($464,000)	$0	($129,000)	$0	'

Credit_Facility_Details

Credit Facility (Details) (USD $)

Sep. 30, 2014

Jan. 23, 2014

Dec. 31, 2013

Jul. 24, 2013

Jul. 24, 2013

Jul. 24, 2013

Jul. 24, 2013

Sep. 30, 2014

Jul. 24, 2013

Oct. 25, 2012

25-May-12

Jul. 24, 2013

Jul. 24, 2013

Jul. 24, 2013

Jul. 24, 2013

Sep. 30, 2014

Jul. 24, 2014

Apr. 24, 2014

Jan. 24, 2014

Jul. 24, 2013

Jul. 24, 2013

Jul. 24, 2013

Jul. 24, 2013

Jul. 24, 2013

Jul. 24, 2013

Jul. 24, 2013

Jul. 24, 2013

Jul. 24, 2013

Jul. 24, 2013

Jul. 24, 2013

Jul. 24, 2013

Jul. 24, 2013

loan

KeyBank, National Association

KeyBank, National Association

KeyBank, National Association

KeyBank, National Association

KeyBank, National Association

KeyBank, National Association

KeyBank, National Association

KeyBank, National Association

KeyBank, National Association

KeyBank, National Association

KeyBank, National Association

KeyBank, National Association

Term Loan

Term Loan

Term Loan

Term Loan

Term Loan

Term Loan

Term Loan

Credit facility

Credit facility

Corporate Leverage Ratio

Corporate Leverage Ratio

Corporate Leverage Ratio

Corporate Leverage Ratio

Credit Rating, Major Credit Rating Agencies

Credit Rating, Major Credit Rating Agencies

Credit Rating, Major Credit Rating Agencies

Credit Rating, Major Credit Rating Agencies

Above Threshold

Below Threshold

Subfacility

Credit facility

Credit facility

Credit facility

Credit facility

Credit facility

Credit facility

Credit facility

Credit Facility

Credit Facility

KeyBank, National Association

KeyBank, National Association

KeyBank, National Association

KeyBank, National Association

KeyBank, National Association

KeyBank, National Association

KeyBank, National Association

KeyBank, National Association

KeyBank, National Association

KeyBank, National Association

KeyBank, National Association

KeyBank, National Association

KeyBank, National Association

extension

Federal Funds Effective Rate Plus

One-Month LIBOR

Maximum

Credit facility

Credit facility

Maximum

Credit facility

Credit facility

Credit facility

Credit facility

Credit facility

Credit facility

Credit facility

Credit facility

Line of Credit Facility, Base Rate, Option Two

Line of Credit Facility, Base Rate, Option Three

Maximum

LIBOR

LIBOR

Base Rate

Base Rate

LIBOR

LIBOR

Base Rate

Base Rate

Line of Credit Facility, Interest Rate, Option One

Line of Credit Facility, Interest Rate, Option One

Line of Credit Facility, Interest Rate, Option Two

Line of Credit Facility, Interest Rate, Option Two

Line of Credit Facility, Interest Rate, Option One

Line of Credit Facility, Interest Rate, Option One

Line of Credit Facility, Interest Rate, Option Two

Line of Credit Facility, Interest Rate, Option Two

Minimum

Maximum

Minimum

Maximum

Minimum

Maximum

Minimum

Maximum

Line of Credit Facility [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Maximum capacity on credit facility

'

'

'

'

'

$25,000,000

'

'

'

$200,000,000

$50,000,000

'

'

$755,000,000

'

'

$200,000,000

$400,000,000

$500,000,000

'

$500,000,000

'

$255,000,000

'

'

'

'

'

'

'

'

'

Additional borrowing capacity

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,200,000,000

'

'

'

'

'

'

750,000,000

'

450,000,000

'

'

'

'

'

'

'

'

Spread on variable rate basis

'

'

'

'

'

'

'

'

'

'

'

0.50%

1.00%

'

'

'

'

'

'

'

'

'

'

'

1.60%

2.20%

0.35%

0.95%

0.95%

1.70%

0.00%

0.70%

Unused capacity, commitment fee percentage

'

'

'

0.25%

0.15%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Commitment fee percentage, threshold, unused capacity as a percentage of current capacity

'

'

'

'

'

'

'

'

50.00%

'

'

'

'

'

'

'

'

'

'

0.25%

'

'

'

'

'

'

'

'

'

'

'

'

Number of extension options (extensions)

'

'

'

'

'

'

'

'

2

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Extension option of credit facility

'

'

'

'

'

'

'1 year

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Maximum number of term loans (loans)

'

5

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Potential additional loan commitment maximum

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

750,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Credit facility

619,400,000

'

0

'

'

'

'

619,400,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Weighted average interest rate (percent)

'

'

'

'

'

'

'

1.80%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Unused borrowing capacity

'

'

'

'

'

'

'

$54,300,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Note_Payable_Details

Note Payable (Details) (Notes Payable, Other Payables, USD $)	1 Months Ended
	Sep. 30, 2011
	extension
Notes Payable, Other Payables	'
Debt Instrument [Line Items]	'
Note payable, face amount	$4,500,000
Fixed rate of interest on note payable	8.00%
Number of extension options (extensions)	2
Term of extension option	'1 year
Notice period required for mandatory repayment	'60 days

Mortgage_Notes_Payable_Schedul

Mortgage Notes Payable (Schedule of Mortgage Notes Payable) (Details) (USD $)	Sep. 30, 2014		Dec. 31, 2013
In Thousands, unless otherwise specified
Debt Instrument [Line Items]	'		'
Outstanding Loan Amount as of	$303,831		$259,348
Mortgage notes payable and premiums, net	'		'
Debt Instrument [Line Items]	'		'
Encumbered Properties (properties)	32		'
Outstanding Loan Amount as of	303,831		259,348
Effective Interest Rate (percent)	5.17%	[1]	'
Mortgage notes payable and premiums, net | Multi Tranche Mortgage Loan [Member]	'		'
Debt Instrument [Line Items]	'		'
Number of properties under multi-tranche loan (properties)	8		'
Mortgage notes payable and premiums, net | Multi Tranche Mortgage Loan, First, Second and Third Tranche	'		'
Debt Instrument [Line Items]	'		'
Outstanding Loan Amount as of	106,200		'
Mortgage notes payable and premiums, net | Texarkana ASC - Texarkana, TX	'		'
Debt Instrument [Line Items]	'		'
Encumbered Properties (properties)	1		'
Outstanding Loan Amount as of	2,108		2,143
Effective Interest Rate (percent)	5.58%		'
Mortgage notes payable and premiums, net | Carson Tahoe Specialty Medical Center - Carson City, NV	'		'
Debt Instrument [Line Items]	'		'
Encumbered Properties (properties)	3	[2]	'
Outstanding Loan Amount as of	21,751	[2]	21,751	[2]
Effective Interest Rate (percent)	5.08%	[2]	'
Mortgage notes payable and premiums, net | Durango Medical Plaza - Las Vegas, NV	'		'
Debt Instrument [Line Items]	'		'
Encumbered Properties (properties)	1	[2]	'
Outstanding Loan Amount as of	17,172	[2]	17,172	[2]
Effective Interest Rate (percent)	5.08%	[2]	'
Mortgage notes payable and premiums, net | CareMeridian Rehabilitation - Phoenix, AZ	'		'
Debt Instrument [Line Items]	'		'
Encumbered Properties (properties)	1	[2]	'
Outstanding Loan Amount as of	6,936	[2]	6,936	[2]
Effective Interest Rate (percent)	5.08%	[2]	'
Mortgage notes payable and premiums, net | Reliant Rehabilitation - Dallas, TX	'		'
Debt Instrument [Line Items]	'		'
Encumbered Properties (properties)	1	[2]	'
Outstanding Loan Amount as of	24,850	[2]	24,850	[2]
Effective Interest Rate (percent)	5.15%	[2]	'
Mortgage notes payable and premiums, net | Select Rehabilitation - San Antonio, TX	'		'
Debt Instrument [Line Items]	'		'
Encumbered Properties (properties)	1	[2]	'
Outstanding Loan Amount as of	12,714	[2]	12,714	[2]
Effective Interest Rate (percent)	5.15%	[2]	'
Mortgage notes payable and premiums, net | Spring Creek Medical Plaza - Tomball, TX	'		'
Debt Instrument [Line Items]	'		'
Encumbered Properties (properties)	1	[2]	'
Outstanding Loan Amount as of	7,477	[2]	7,477	[2]
Effective Interest Rate (percent)	5.15%	[2]	'
Mortgage notes payable and premiums, net | Odessa Regional MOB - Odessa, TX	'		'
Debt Instrument [Line Items]	'		'
Encumbered Properties (properties)	1		'
Outstanding Loan Amount as of	4,047		4,047
Effective Interest Rate (percent)	4.09%	[3]	'
Mortgage notes payable and premiums, net | Methodist North MOB - Peoria, IL	'		'
Debt Instrument [Line Items]	'		'
Encumbered Properties (properties)	1		'
Outstanding Loan Amount as of	13,544		13,544
Effective Interest Rate (percent)	3.99%	[3]	'
Mortgage notes payable and premiums, net | University of Wisconsin Health MOB - Monona, WI	'		'
Debt Instrument [Line Items]	'		'
Encumbered Properties (properties)	1		'
Outstanding Loan Amount as of	5,039		5,039
Effective Interest Rate (percent)	4.00%		'
Mortgage notes payable and premiums, net | Reliant Rehabilitation - Houston, TX	'		'
Debt Instrument [Line Items]	'		'
Encumbered Properties (properties)	1	[2]	'
Outstanding Loan Amount as of	13,437	[2]	13,437	[2]
Effective Interest Rate (percent)	4.98%	[2]	'
Mortgage notes payable and premiums, net | Village Healthcare Center - Santa Ana	'		'
Debt Instrument [Line Items]	'		'
Encumbered Properties (properties)	1	[2]	'
Outstanding Loan Amount as of	1,906	[2]	1,906	[2]
Effective Interest Rate (percent)	4.98%	[2]	'
Mortgage notes payable and premiums, net | Sisters of Mercy Building - Springfield, MO	'		'
Debt Instrument [Line Items]	'		'
Encumbered Properties (properties)	1		'
Outstanding Loan Amount as of	5,500		5,500
Effective Interest Rate (percent)	4.11%		'
Mortgage notes payable and premiums, net | East Pointe Medical Plaza - Lehigh Acres, FL	'		'
Debt Instrument [Line Items]	'		'
Encumbered Properties (properties)	1		'
Outstanding Loan Amount as of	5,260		5,260
Effective Interest Rate (percent)	4.11%		'
Mortgage notes payable and premiums, net | Unitron Hearing Building - Plymouth, MN	'		'
Debt Instrument [Line Items]	'		'
Encumbered Properties (properties)	1		'
Outstanding Loan Amount as of	4,000		4,000
Effective Interest Rate (percent)	4.11%		'
Mortgage notes payable and premiums, net | Carson Tahoe MOB West - Carson City, NV	'		'
Debt Instrument [Line Items]	'		'
Encumbered Properties (properties)	1		'
Outstanding Loan Amount as of	4,675		4,675
Effective Interest Rate (percent)	3.88%	[3]	'
Mortgage notes payable and premiums, net | Aurora Health Care Portfolio	'		'
Debt Instrument [Line Items]	'		'
Encumbered Properties (properties)	3		'
Outstanding Loan Amount as of	49,600		49,600
Effective Interest Rate (percent)	5.60%		'
Mortgage notes payable and premiums, net | Princeton Village - Clackamas, OR	'		'
Debt Instrument [Line Items]	'		'
Encumbered Properties (properties)	1		'
Outstanding Loan Amount as of	3,044		3,114
Effective Interest Rate (percent)	7.48%		'
Mortgage notes payable and premiums, net | Pelican Pointe - Klamath Falls, OR	'		'
Debt Instrument [Line Items]	'		'
Encumbered Properties (properties)	1		'
Outstanding Loan Amount as of	12,318		12,460
Effective Interest Rate (percent)	5.16%		'
Mortgage notes payable and premiums, net | Fayette MOB - Fayetteville, GA	'		'
Debt Instrument [Line Items]	'		'
Encumbered Properties (properties)	1		'
Outstanding Loan Amount as of	6,859		6,986
Effective Interest Rate (percent)	5.18%		'
Mortgage notes payable and premiums, net | Garden House - Anderson, SC	'		'
Debt Instrument [Line Items]	'		'
Encumbered Properties (properties)	1		'
Outstanding Loan Amount as of	8,048		8,149
Effective Interest Rate (percent)	4.86%		'
Mortgage notes payable and premiums, net | Benton House - Covington, GA	'		'
Debt Instrument [Line Items]	'		'
Encumbered Properties (properties)	1		'
Outstanding Loan Amount as of	8,030		8,121
Effective Interest Rate (percent)	5.26%		'
Mortgage notes payable and premiums, net | Arbor Terrace - Asheville, SC	'		'
Debt Instrument [Line Items]	'		'
Encumbered Properties (properties)	1		'
Outstanding Loan Amount as of	9,402		9,497
Effective Interest Rate (percent)	5.58%		'
Mortgage notes payable and premiums, net | Arbor Terrace - Decatur, GA	'		'
Debt Instrument [Line Items]	'		'
Encumbered Properties (properties)	1		'
Outstanding Loan Amount as of	10,860		10,970
Effective Interest Rate (percent)	5.57%		'
Mortgage notes payable and premiums, net | Casa de Santa Fe - Rocklin, CA	'		'
Debt Instrument [Line Items]	'		'
Encumbered Properties (properties)	1		'
Outstanding Loan Amount as of	20,491		0
Effective Interest Rate (percent)	4.71%		'
Mortgage notes payable and premiums, net | Bay Medical Plaza - Lynn Haven, FL	'		'
Debt Instrument [Line Items]	'		'
Encumbered Properties (properties)	1		'
Outstanding Loan Amount as of	9,579		0
Effective Interest Rate (percent)	6.61%		'
Mortgage notes payable and premiums, net | Bay Medical Center - Panama City, FL	'		'
Debt Instrument [Line Items]	'		'
Encumbered Properties (properties)	1		'
Outstanding Loan Amount as of	9,321		0
Effective Interest Rate (percent)	6.61%		'
Mortgage notes payable and premiums, net | Legacy Heart Center - Plano, TX	'		'
Debt Instrument [Line Items]	'		'
Encumbered Properties (properties)	1		'
Outstanding Loan Amount as of	$5,863		$0
Effective Interest Rate (percent)	5.76%		'
[1]	Calculated on a weighted average basis for all mortgages outstanding as of SeptemberB 30, 2014.
[2]	These mortgages, aggregating $106.2 million, represent the first, second and third tranches of a multi-tranche mortgage loan agreement to provide funding for a portfolio of eight properties. The mortgages for each of the properties are cross-collateralized with one another and in the event that the Company defaults on one of the mortgages, the lender may look to the other properties as collateral. During the three months ended September 30, 2014, the maturity date on these mortgages was extended to September 2017 from September 2015.
[3]	Fixed as a result of entering into a swap agreement.

Mortgage_Notes_Payable_Schedul1

Mortgage Notes Payable (Schedule Of Aggregate Future Principal Payments On Mortgage Notes Payable) (Details) (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Debt Instrument [Line Items]	'	'
Total	$303,831	$259,348
Mortgage notes payable and premiums, net	'	'
Debt Instrument [Line Items]	'	'
October 1, 2014 b December 31, 2014	393	'
2015	13,937	'
2016	20,936	'
2017	200,596	'
2018	27,778	'
Thereafter	40,191	'
Total	$303,831	$259,348

Subordinated_Listing_Distribut1

Subordinated Listing Distributed Derivative (Details) (USD $)	9 Months Ended
In Thousands, except Share data, unless otherwise specified	Sep. 30, 2014
Listing Distribution Derivative [Line Items]	'
Listing note, fair value	56,400
New York Recovery Advisors, LLC | Excess of Adjusted Market Value of Real Estate Assets Plus Distributions Over Aggregate Contributed Investor Capital | Advisor	'
Listing Distribution Derivative [Line Items]	'
Subordinated incentive listing distribution as a percentage of the benchmark	15.00%
Minimum	'
Listing Distribution Derivative [Line Items]	'
Number of days after listing the value of the units are determined	'180 days
Maximum	'
Listing Distribution Derivative [Line Items]	'
Number of days after listing the value of the units are determined	'210 days
Annual Targeted Investor Return | New York Recovery Advisors, LLC | Pre-tax Non-compounded Return on Capital Contribution | Advisor	'
Listing Distribution Derivative [Line Items]	'
Cumulative capital investment return	6.00%
Ventas, Inc | Operating Partnership Unit	'
Listing Distribution Derivative [Line Items]	'
OP units to be issued in respect of the termination of the Listing Note Agreement (in units)	5,613,374

Fair_Value_of_Financial_Instru2

Fair Value of Financial Instruments (Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis) (Details) (USD $)

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Dec. 31, 2013

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Dec. 31, 2013

Sep. 30, 2014

Dec. 31, 2013

Sep. 30, 2014

Dec. 31, 2013

Sep. 30, 2014

Dec. 31, 2013

Sep. 30, 2014

Dec. 31, 2013

Sep. 30, 2014

Dec. 31, 2013

Sep. 30, 2014

Dec. 31, 2013

Sep. 30, 2014

Dec. 31, 2013

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Fair Value, Measurements, Recurring

Fair Value, Measurements, Recurring

Fair Value, Measurements, Recurring

Fair Value, Measurements, Recurring

Interest rate swaps

Interest rate swaps

Interest rate swaps

Interest rate swaps

Interest rate swaps

Interest rate swaps

Interest rate swaps

Interest rate swaps

Investment securities

Investment securities

Investment securities

Investment securities

Investment securities

Investment securities

Investment securities

Investment securities

OPP

OPP

OPP

OPP

OPP

OPP

Quoted Prices in Active Markets Level 1

Significant Other Observable Inputs Level 2

Significant Unobservable Inputs Level 3

Fair Value, Measurements, Recurring

Fair Value, Measurements, Recurring

Fair Value, Measurements, Recurring

Fair Value, Measurements, Recurring

Fair Value, Measurements, Recurring

Fair Value, Measurements, Recurring

Fair Value, Measurements, Recurring

Fair Value, Measurements, Recurring

Fair Value, Measurements, Recurring

Fair Value, Measurements, Recurring

Fair Value, Measurements, Recurring

Fair Value, Measurements, Recurring

Fair Value, Measurements, Recurring

Fair Value, Measurements, Recurring

Fair Value, Measurements, Recurring

Fair Value, Measurements, Recurring

Fair Value, Measurements, Recurring

Fair Value, Measurements, Recurring

Fair Value, Measurements, Recurring

Fair Value, Measurements, Recurring

Significant Unobservable Inputs Level 3

Significant Unobservable Inputs Level 3

Fair Value

Quoted Prices in Active Markets Level 1

Quoted Prices in Active Markets Level 1

Significant Other Observable Inputs Level 2

Significant Other Observable Inputs Level 2

Significant Unobservable Inputs Level 3

Significant Unobservable Inputs Level 3

Fair Value

Quoted Prices in Active Markets Level 1

Quoted Prices in Active Markets Level 1

Significant Other Observable Inputs Level 2

Significant Other Observable Inputs Level 2

Significant Unobservable Inputs Level 3

Significant Unobservable Inputs Level 3

Quoted Prices in Active Markets Level 1

Significant Other Observable Inputs Level 2

Significant Unobservable Inputs Level 3

Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Interest rate swaps

'

($233,000)

'

($333,000)

'

'

'

'

($233,000)

($333,000)

$0

$0

($233,000)

($333,000)

$0

$0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Investment securities

'

1,587,000

'

14,670,000

'

'

'

'

'

'

'

'

'

'

'

'

1,587,000

14,670,000

1,587,000

14,670,000

0

0

0

0

'

'

'

'

'

'

OPP

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

-1,285,000

[1]

0

[1]

0

[1]

-1,285,000

[1]

'

'

Listing Note

'

-56,400,000

'

'

-56,400,000

0

0

-56,400,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Equity-based compensation

0

'

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

200,000

700,000

Transfers from level 1 to level 2

'

$0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

[1]

Carrying values include $303.8 million and $259.3 million mortgage notes payable and $3.6 million and $2.8 million net mortgage premiums as of SeptemberB 30, 2014 and DecemberB 31, 2013, respectively.

Fair_Value_of_Financial_Instru3

Fair Value of Financial Instruments Unobservable Input Reconciliation (Details) (Significant Unobservable Inputs Level 3, USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014
OPP	'
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'
Beginning balance	$0
Fair value at issuance	33,200
Fair value adjustments	-31,915
Ending balance	1,285
Listing Note	'
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'
Beginning balance	0
Fair value at issuance	27,400
Fair value adjustments	29,000
Ending balance	$56,400

Fair_Value_of_Financial_Instru4

Fair Value of Financial Instruments Fair Value Techniques (Details) (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Listing note, fair value	56,400
Fair Value, Measurements, Recurring	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Listing note, fair value	56,400
Fair Value, Measurements, Recurring | Significant Unobservable Inputs Level 3	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Listing note, fair value	56,400
Listing Note | Fair Value, Measurements, Recurring | Significant Unobservable Inputs Level 3	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Merger Probability	95.00%
Listing Note | Monte Carlo Simulation | Fair Value, Measurements, Recurring | Significant Unobservable Inputs Level 3	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Listing note, fair value	56,400
Expected volatility	20.00%
OPP | Fair Value, Measurements, Recurring | Significant Unobservable Inputs Level 3	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Merger Probability	95.00%
OPP | Monte Carlo Simulation | Fair Value, Measurements, Recurring | Significant Unobservable Inputs Level 3	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Fair value, OPP	1,285
Expected volatility	23.00%

Fair_Value_of_Financial_Instru5

Fair Value of Financial Instruments (Narrative) (Details) (Operating Partnership Unit, Ventas, Inc)	Sep. 30, 2014
Operating Partnership Unit | Ventas, Inc	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
OP units to be issued in respect of the termination of the Listing Note Agreement (in units)	5,613,374

Fair_Value_of_Financial_Instru6

Fair Value of Financial Instruments (Fair Value, by Balance Sheet Grouping) (Details) (USD $)	Sep. 30, 2014		Dec. 31, 2013
In Thousands, unless otherwise specified
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'		'
Mortgage notes payable	$303,831		$259,348
Debt Instrument, Unamortized Discount (Premium), Net	-3,612		-2,769
Mortgage notes payable and premiums, net	'		'
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'		'
Mortgage notes payable	303,831		259,348
Significant Unobservable Inputs Level 3 | Mortgage notes payable and premiums, net | Carrying Amount	'		'
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'		'
Debt, fair value	307,443	[1]	262,117	[1]
Mortgage notes payable	303,800		259,300
Debt Instrument, Unamortized Discount (Premium), Net	3,600		2,800
Significant Unobservable Inputs Level 3 | Mortgage notes payable and premiums, net | Fair Value	'		'
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'		'
Debt, fair value	316,664	[1]	266,242	[1]
Significant Unobservable Inputs Level 3 | Credit facility | Carrying Amount	'		'
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'		'
Debt, fair value	619,400		0
Significant Unobservable Inputs Level 3 | Credit facility | Fair Value	'		'
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'		'
Debt, fair value	619,400		0
Significant Unobservable Inputs Level 3 | Preferred equity investment | Carrying Amount	'		'
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'		'
Debt, fair value	8,800		0
Significant Unobservable Inputs Level 3 | Preferred equity investment | Fair Value	'		'
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'		'
Debt, fair value	$8,800		$0
[1]	Carrying values include $303.8 million and $259.3 million mortgage notes payable and $3.6 million and $2.8 million net mortgage premiums as of SeptemberB 30, 2014 and DecemberB 31, 2013, respectively.

Interest_Rate_Derivatives_and_2

Interest Rate Derivatives and Hedging Activities (Narrative) (Details) (USD $)	9 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2014
Derivative [Line Items]	'
Interest rate derivatives, at fair value, including adjustments for nonperformance risk	$0.20
Designated as Hedging Instrument | Cash Flow Hedging | Interest rate swaps	'
Derivative [Line Items]	'
Assets needed for immediate settlement	0.2
Designated as Hedging Instrument | Cash Flow Hedging | Interest rate swaps | Interest Expense	'
Derivative [Line Items]	'
Reclassification period from other comprehensive income as an increase to interest expense	'12 months
Reclassified from other comprehensive income as an increase to interest expense	$0.20

Interest_Rate_Derivatives_and_3

Interest Rate Derivatives and Hedging Activities (Schedule Of Interest Rate Derivative) (Details) (Designated as Hedging Instrument, Cash Flow Hedging, Interest rate swaps, USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified	derivative	derivative
Designated as Hedging Instrument | Cash Flow Hedging | Interest rate swaps	'	'
Derivative [Line Items]	'	'
Number of Instruments	3	3
Notional Amount	$22,266	$22,266

Interest_Rate_Derivatives_and_4

Interest Rate Derivatives and Hedging Activities (Schedule of Derivative Instruments in Statement of Financial Position, Fair Value) (Details) (Cash Flow Hedging, Interest rate swaps, Designated as Hedging Instrument, Derivatives at Fair Value, USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Cash Flow Hedging | Interest rate swaps | Designated as Hedging Instrument | Derivatives at Fair Value	'	'
Derivatives, Fair Value [Line Items]	'	'
Interest rate swaps	($233)	($333)

Interest_Rate_Derivatives_and_5

Interest Rate Derivatives and Hedging Activities (Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance) (Details) (Cash Flow Hedging, Interest rate swaps, USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'	'
Amount of income (loss) recognized in accumulated other comprehensive loss from interest rate derivatives (effective portion)	$42	($139)	($92)	$83
Amount of gain (loss) recognized in income on derivative instruments (ineffective portion and amount excluded from effectiveness testing)	0	0	0	0
Interest Expense	'	'	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'	'
Amount of loss reclassified from accumulated other comprehensive loss into income as interest expense (effective portion)	($65)	($62)	($192)	($183)

Interest_Rate_Derivatives_and_6

Interest Rate Derivatives and Hedging Activities (Schedule of Offsetting Liabilities) (Details) (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Derivative Instruments and Hedging Activities Disclosure [Abstract]	'	'
Gross Amounts of Recognized Liabilities	($233)	($333)
Gross Amounts Offset on the Balance Sheet	0	0
Net Amounts of Liabilities presented on the Balance Sheet	-233	-333
Financial Instruments	0	0
Cash Collateral Posted	0	0
Net Amount	($233)	($333)

Common_Stock_Details

Common Stock (Details) (USD $)	0 Months Ended	9 Months Ended			0 Months Ended
In Thousands, except Share data, unless otherwise specified	Dec. 10, 2011	Sep. 30, 2014	Sep. 30, 2013	Dec. 31, 2013	2-May-14	Apr. 07, 2014
					Tender Offer	Tender Offer
Equity, Class of Treasury Stock [Line Items]	'	'	'	'	'	'
Common stock, outstanding (in shares)	'	169,316,247	'	180,463,898	'	'
Share repurchased (in shares)	'	'	'	'	13,600,000	'
Treasury stock price (in dollars per share)	'	'	'	'	$11	$11
Common stock repurchases, inclusive of fees and expenses	'	($152,144)	($1,764)	'	($150,100)	'
Dividends declared per day (in dollars per share)	$0.00	'	'	'	'	'
Dividends declared (in dollars per share)	$0.68	'	'	'	'	'

Common_Stock_Schedule_of_Treas

Common Stock Schedule of Treasury Stock (Details) (Funded, USD $)	9 Months Ended	40 Months Ended	49 Months Ended
	Sep. 30, 2014	Dec. 31, 2013	Sep. 30, 2014
	request	request	request
Funded	'	'	'
Class of Stock [Line Items]	'	'	'
Number of Requests	22	122	144
Number of Shares Repurchased (in shares)	69,476	386,968	456,444
Treasury stock price (in dollars per share)	$9.85	$9.77	$9.79

Commitments_and_Contingencies_1

Commitments and Contingencies (Schedule of Future Minimum Rental Payments for Operating Leases) (Details) (USD $)	Sep. 30, 2014	Jul. 31, 2014
Recorded Unconditional Purchase Obligation [Line Items]	'	'
October 1, 2014 b December 31, 2014	$167,000	'
2015	627,000	'
2016	634,000	'
2017	641,000	'
2018	664,000	'
Thereafter	23,553,000	'
Total	26,286,000	'
Purchase Obligation	'	24,500,000
Land	'	'
Recorded Unconditional Purchase Obligation [Line Items]	'	'
Development in Process	1,700,000	'
Construction in Progress	'	'
Recorded Unconditional Purchase Obligation [Line Items]	'	'
Development in Process	$19,700,000	'

Commitments_and_Contingencies_2

Commitments and Contingencies (Details)	Sep. 30, 2014
	lawsuit
Commitments and Contingencies Disclosure [Abstract]	'
Number of lawsuits	13

Related_Party_Transactions_and2

Related Party Transactions and Arrangements (Details) (USD $)

3 Months Ended

9 Months Ended

0 Months Ended

3 Months Ended

9 Months Ended

12 Months Ended

0 Months Ended

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

12 Months Ended

0 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Dec. 31, 2013

Sep. 30, 2014

Apr. 07, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Dec. 31, 2013

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Dec. 31, 2013

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Apr. 07, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Apr. 07, 2014

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Dec. 31, 2013

Sep. 30, 2014

Sep. 30, 2014

Apr. 07, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

31-May-14

Sep. 30, 2014

Advisor

Advisor

RCS Advisory Services, LLC

New York Recovery Advisors, LLC

American Realty Capital Healthcare Special Limited Partnership, LLC

American Realty Capital Healthcare Special Limited Partnership, LLC

Realty Capital Securities, LLC and American National Stock Transfer, LLC

Realty Capital Securities, LLC and American National Stock Transfer, LLC

Realty Capital Securities, LLC and American National Stock Transfer, LLC

Realty Capital Securities, LLC and American National Stock Transfer, LLC

Realty Capital Securities, LLC

Realty Capital Securities, LLC

Realty Capital Securities, LLC

American Realty Capital Healthcare Advisors, LLC

American Realty Capital Healthcare Advisors, LLC

American Realty Capital Healthcare Advisors, LLC

American Realty Capital Healthcare Advisors, LLC

American Realty Capital Healthcare Advisors, LLC

American Realty Capital Healthcare Advisors, LLC

American Realty Capital Healthcare Advisors, LLC

American Realty Capital Healthcare Advisors, LLC

American Realty Capital Healthcare Advisors, LLC

American Realty Capital Healthcare Advisors, LLC

American Realty Capital Healthcare Advisors, LLC

American Realty Capital Healthcare Advisors, LLC

American Realty Capital Healthcare Advisors, LLC

American Realty Capital Healthcare Advisors, LLC

American Realty Capital Healthcare Advisors, LLC

American Realty Capital Trust IV Advisors, LLC

RCS Advisory Services, LLC

RCS Advisory Services, LLC

RCS Advisory Services, LLC

RCS Advisory Services, LLC

RCS Advisory Services, LLC

Greater Of

Greater Of

Class B units

Real Estate Investment Fund

Strategic and Financial Advisory Services Fee

Strategic and Financial Advisory Services Fee

Strategic and Financial Advisory Services Fee

Strategic and Financial Advisory Services Fee

General Legal, Marketing and Sales

General Legal, Marketing and Sales

General Legal, Marketing and Sales

General Legal, Marketing and Sales

Fees Incurred in Connection With Merger

Fees Incurred in Connection With Merger

Fees Incurred in Connection With Merger

Fees Incurred in Connection With Merger

Fees Incurred in Connection With Merger

Fees Incurred in Connection With Merger

Fees Incurred in Connection With Merger

Fees Incurred in Connection With Merger

Services for Preparation of the Merger

Services for Preparation of the Merger

Services for Preparation of the Merger

Services for Preparation of the Merger

Services for Preparation of the Merger

Services for Preparation of the Merger

Services for Preparation of the Merger

Services for Preparation of the Merger

Services for Preparation of the Merger

Accounts Payable and Accrued Liabilities

Contract Purchase Price

Advisor

Entity Wholly Owned by Sponsor

Entity Wholly Owned by Sponsor

Dealer Manager and Transfer Agent

Dealer Manager and Transfer Agent

Dealer Manager and Transfer Agent

Dealer Manager and Transfer Agent

Dealer Manager

Dealer Manager

Dealer Manager

Advisor

Advisor

Advisor

Advisor

Advisor

Advisor

Advisor

Advisor

Advisor

Advisor

Advisor

Advisor

Advisor

Advisor

Advisor

Advisor

Transaction Management

Transaction Management

Transaction Management

Transaction Management

Transaction Management

American Realty Capital Healthcare Advisors, LLC

American Realty Capital Healthcare Advisors, LLC

Sponsor

Dealer Manager and Transfer Agent

Dealer Manager and Transfer Agent

Dealer Manager and Transfer Agent

Dealer Manager and Transfer Agent

Affiliated Entity

Affiliated Entity

Affiliated Entity

Affiliated Entity

Dealer Manager

Dealer Manager

Dealer Manager

Dealer Manager

RCS Advisory Services, LLC

RCS Advisory Services, LLC

RCS Advisory Services, LLC

RCS Advisory Services, LLC

American National Stock Transfer, LLC

American National Stock Transfer, LLC

American National Stock Transfer, LLC

American National Stock Transfer, LLC

American National Stock Transfer, LLC

Fees Incurred in Connection With Merger

Annual Targeted Investor Return

Information Agent and Advisory Service Fee

Transaction Value

Maximum

Maximum

Contract Purchase Price

Contract Purchase Price

Advance on Loan or Other Investment

Amount Available or Outstanding Under Financing Arrangement

Gross Revenue, Stand-alone Single-tenant Net Leased Properties

Gross Revenue, Excluding Stand-alone Single-tenant Net Leased Properties

Absorbed General and Administrative Expenses, Receivable

Absorbed General and Administrative Expenses, Receivable

Absorbed General and Administrative Expenses, Receivable

Absorbed General and Administrative Expenses, Receivable

Maximum

Maximum

Maximum

Maximum

Maximum

Average Invested Assets

Advisor

Advisor

Dealer Manager

Dealer Manager

Dealer Manager

Dealer Manager

Dealer Manager

Dealer Manager

Dealer Manager

Dealer Manager

Dealer Manager

RCS Advisory Services, LLC

Pre-tax Non-compounded Return on Capital Contribution

Gross Proceeds, Initial Public Offering

Gross Proceeds, Common Stock

Contract Purchase Price

Gross Revenue, Managed Properties

Contract Sales Price

Brokerage Commission Fees

Real Estate Commissions

Maximum

Maximum

Dealer Manager

Contract Sales Price

Contract Sales Price

Average Invested Assets

Net Income, Excluding Additions to Non-cash Reserves and Gains on Sales of Assets

Related Party Transaction [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Operating partnership units held by related party (in shares)

'

'

'

'

'

1,443,897

'

'

'

20,000

20,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Limited partners' expected contributed capital

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$800,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

LLC or LP Member Units or Limited Partners, Expected Ownership Interest, (in shares)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

83,333

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Related party expense

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0

0

0

300,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

3,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Proceeds from sale of investment

1,500,000

'

1,500,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Gain on investment

37,000

'

37,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Cost of investments

1,573,000

'

1,573,000

'

17,580,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Sales commissions as a percentage of benchmark

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

7.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Gross proceeds from sale

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

3.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Acquisition fees earned

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Financing advance fees

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Financing advance fees

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0.50%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Acquisition fees and acquisition related expenses

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

4.50%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Financing coordination as a percentage of benchmark

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Transaction fee earned

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0.25%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Quarterly asset management

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0.19%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Cumulative capital investment return

'

'

'

'

'

'

'

'

6.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Unearned class B unit (in shares)

'

'

'

'

'

'

1,360,362

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Equity-based compensation

'

0

'

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

12,900,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Asset management fees as a percentage of benchmark

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0.50%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Asset management invested asset maximum for fee determination

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

3,000,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Asset management invested asset maximum

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0.40%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Property management fees as a percentage of benchmark

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1.50%

2.50%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Oversight fees earned by related party

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Operating expenses as a percentage of benchmark

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2.00%

25.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Transaction management fee earned

'

'

'

'

'

'

'

3,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Fees paid to related parties

'

'

'

'

'

'

'

'

'

'

'

0

0

1,300,000

600,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0

0

1,500,000

0

1,500,000

'

'

'

'

0

0

6,400,000

0

0

0

1,500,000

0

1,000,000

0

1,000,000

0

'

'

'

'

100,000

0

200,000

0

1,300,000

0

1,900,000

0

'

'

Due to Related Parties

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

3,000,000

'

3,000,000

'

100,000

'

100,000

'

1,500,000

'

1,500,000

'

'

3,000,000

Due to affiliate

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,900,000

'

Information agent and advisory service

'

'

'

'

'

'

'

'

'

'

'

1,900,000

'

1,900,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Listing advisory fee

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0.25%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Acquisition and transaction related

10,266,000

3,107,000

36,144,000

7,858,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,000,000

0

3,000,000

0

'

'

'

'

'

'

'

'

'

'

Strategic advisory services fee

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0.25%

'

0.25%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Advisory services fee amount

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,000,000

'

1,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Base advisory services fee

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$1,000,000

'

$1,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Real estate commissions as a percentage of benchmark

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2.00%

50.00%

6.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Related_Party_Transactions_and3

Related Party Transactions and Arrangements (Schedule of Amount Contractually Due and Forgiven in Connection With Operation Related Services) (Details) (USD $)	3 Months Ended				9 Months Ended
	Sep. 30, 2014		Sep. 30, 2013		Sep. 30, 2014		Sep. 30, 2013		Dec. 31, 2013
Total related party operation fees and reimbursements	'		'		'		'		'
Related Party Transaction [Line Items]	'		'		'		'		'
Due to affiliate	$213,000		'		$213,000		'		$235,000
One-time fees and reimbursements: | Acquisition fees and related cost reimbursements	'		'		'		'		'
Related Party Transaction [Line Items]	'		'		'		'		'
Due to affiliate	0		'		0		'		0
One-time fees and reimbursements: | Transaction fee	'		'		'		'		'
Related Party Transaction [Line Items]	'		'		'		'		'
Due to affiliate	0		'		0		'		0
One-time fees and reimbursements: | Financing coordination fees	'		'		'		'		'
Related Party Transaction [Line Items]	'		'		'		'		'
Due to affiliate	0		'		0		'		0
One-time fees and reimbursements: | Other expense reimbursements	'		'		'		'		'
Related Party Transaction [Line Items]	'		'		'		'		'
Due to affiliate	0		'		0		'		0
Ongoing fees: | Asset Management Fees	'		'		'		'		'
Related Party Transaction [Line Items]	'		'		'		'		'
Due to affiliate	0	[1]	'		0	[1]	'		0	[1]
Ongoing fees: | Property management and leasing fees	'		'		'		'		'
Related Party Transaction [Line Items]	'		'		'		'		'
Due to affiliate	0		'		0		'		0
Ongoing fees: | Transfer agent and other professional fees	'		'		'		'		'
Related Party Transaction [Line Items]	'		'		'		'		'
Due to affiliate	213,000		'		213,000		'		235,000
Ongoing fees: | Strategic advisory fees	'		'		'		'		'
Related Party Transaction [Line Items]	'		'		'		'		'
Due to affiliate	0		'		0		'		0
Ongoing fees: | Dividends on Class B Units	'		'		'		'		'
Related Party Transaction [Line Items]	'		'		'		'		'
Due to affiliate	0		'		0		'		0
Incurred | Total related party operation fees and reimbursements	'		'		'		'		'
Related Party Transaction [Line Items]	'		'		'		'		'
Related party operation fees and reimbursements	4,212,000		9,471,000		12,806,000		13,728,000		'
Incurred | One-time fees and reimbursements: | Acquisition fees and related cost reimbursements	'		'		'		'		'
Related Party Transaction [Line Items]	'		'		'		'		'
Related party operation fees and reimbursements	1,151,000		697,000		5,684,000		3,577,000		'
Incurred | One-time fees and reimbursements: | Transaction fee	'		'		'		'		'
Related Party Transaction [Line Items]	'		'		'		'		'
Related party operation fees and reimbursements	0		306,000		0		306,000		'
Incurred | One-time fees and reimbursements: | Financing coordination fees	'		'		'		'		'
Related Party Transaction [Line Items]	'		'		'		'		'
Related party operation fees and reimbursements	0		7,784,000		361,000		7,942,000		'
Incurred | One-time fees and reimbursements: | Other expense reimbursements	'		'		'		'		'
Related Party Transaction [Line Items]	'		'		'		'		'
Related party operation fees and reimbursements	0		0		0		19,000		'
Incurred | Ongoing fees: | Asset Management Fees	'		'		'		'		'
Related Party Transaction [Line Items]	'		'		'		'		'
Related party operation fees and reimbursements	2,711,000	[1]	0	[1]	5,063,000	[1]	0	[1]	'
Incurred | Ongoing fees: | Property management and leasing fees	'		'		'		'		'
Related Party Transaction [Line Items]	'		'		'		'		'
Related party operation fees and reimbursements	0		0		0		0		'
Incurred | Ongoing fees: | Transfer agent and other professional fees	'		'		'		'		'
Related Party Transaction [Line Items]	'		'		'		'		'
Related party operation fees and reimbursements	350,000		621,000		1,547,000		847,000		'
Incurred | Ongoing fees: | Strategic advisory fees	'		'		'		'		'
Related Party Transaction [Line Items]	'		'		'		'		'
Related party operation fees and reimbursements	0		0		0		920,000		'
Incurred | Ongoing fees: | Dividends on Class B Units	'		'		'		'		'
Related Party Transaction [Line Items]	'		'		'		'		'
Related party operation fees and reimbursements	0		63,000		151,000		117,000		'
Forgiven | Total related party operation fees and reimbursements	'		'		'		'		'
Related Party Transaction [Line Items]	'		'		'		'		'
Related party operation fees and reimbursements	793,000		370,000		2,105,000		861,000		'
Forgiven | One-time fees and reimbursements: | Acquisition fees and related cost reimbursements	'		'		'		'		'
Related Party Transaction [Line Items]	'		'		'		'		'
Related party operation fees and reimbursements	0		0		0		0		'
Forgiven | One-time fees and reimbursements: | Transaction fee	'		'		'		'		'
Related Party Transaction [Line Items]	'		'		'		'		'
Related party operation fees and reimbursements	0		0		0		0		'
Forgiven | One-time fees and reimbursements: | Financing coordination fees	'		'		'		'		'
Related Party Transaction [Line Items]	'		'		'		'		'
Related party operation fees and reimbursements	0		0		0		0		'
Forgiven | One-time fees and reimbursements: | Other expense reimbursements	'		'		'		'		'
Related Party Transaction [Line Items]	'		'		'		'		'
Related party operation fees and reimbursements	0		0		0		0		'
Forgiven | Ongoing fees: | Asset Management Fees	'		'		'		'		'
Related Party Transaction [Line Items]	'		'		'		'		'
Related party operation fees and reimbursements	0	[1]	0	[1]	0	[1]	0	[1]	'
Forgiven | Ongoing fees: | Property management and leasing fees	'		'		'		'		'
Related Party Transaction [Line Items]	'		'		'		'		'
Related party operation fees and reimbursements	793,000		370,000		2,105,000		861,000		'
Forgiven | Ongoing fees: | Transfer agent and other professional fees	'		'		'		'		'
Related Party Transaction [Line Items]	'		'		'		'		'
Related party operation fees and reimbursements	0		0		0		0		'
Forgiven | Ongoing fees: | Strategic advisory fees	'		'		'		'		'
Related Party Transaction [Line Items]	'		'		'		'		'
Related party operation fees and reimbursements	0		0		0		0		'
Forgiven | Ongoing fees: | Dividends on Class B Units	'		'		'		'		'
Related Party Transaction [Line Items]	'		'		'		'		'
Related party operation fees and reimbursements	0		0		0		0		'
Dealer Manager | Realty Capital Securities, LLC | Total commissions and fees incurred from the Dealer Manager	'		'		'		'		'
Related Party Transaction [Line Items]	'		'		'		'		'
Related party operation fees and reimbursements	0		-48,000		0		117,377,000		'
Due to affiliate	0	[2]	'		0	[2]	'		18,000	[2]
Advisor and Dealer Manager | American Realty Capital Healthcare Advisors, LLC and Realty Capital Securities, LLC [Member] | Fees and expense reimbursements incurred from the Advisor and Dealer Manager	'		'		'		'		'
Related Party Transaction [Line Items]	'		'		'		'		'
Related party operation fees and reimbursements	0		0		0		1,901,000		'
Due to affiliate	$0		'		$0		'		$0
[1]	Prior to the Listing, the Company caused the OP to issue the Advisor restricted performance based Class B units for asset management services, which vested with the Listing. Amounts reflected in the table reflect asset management services following the Listing as described above.
[2]	Includes reimbursements received for selling commissions and dealer manager fees as a result of share purchase cancellations related to common stock sales prior to the close of the IPO

EquityBased_Compensation_Detai

Equity-Based Compensation (Details) (USD $)

1 Months Ended

3 Months Ended

9 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

9 Months Ended

Apr. 28, 2014

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2014

Dec. 31, 2013

Feb. 28, 2011

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Mar. 30, 2014

Sep. 30, 2014

Mar. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Apr. 28, 2014

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2014

Stock Option Plan

Stock Options

Unvested restricted stock

Unvested restricted stock

Unvested restricted stock

Unvested restricted stock

Unvested restricted stock

Unvested restricted stock

Unvested restricted stock

Unvested restricted stock

Common Stock

Common Stock

Minimum

Maximum

Stock Option Plan

Restricted Share Plan

Restricted Share Plan

Restricted Share Plan

Restricted Share Plan

Restricted Share Plan

Restricted Share Plan

Unvested restricted stock

Unvested restricted stock

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Options, fixed exercise price (in dollars per share)

'

'

'

'

'

'

$10

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of shares authorized (in shares)

'

'

'

'

'

'

'

500,000

'

'

'

7,500,000

'

'

'

'

'

'

'

'

Shares granted automatically upon election to board of directors (in shares)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

3,000

'

'

'

'

Vesting period

'5 years

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'3 years

'5 years

Periodic vesting percentage

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

20.00%

'

'

'

'

Maximum authorized amount as a percentage of shares authorized

'

'

'

'

'

'

'

'

'

'

'

5.00%

'

'

'

'

'

'

'

'

Common stock, par value (in dollars per share)

'

'

'

$0.01

$0.01

$0.01

'

'

'

$0.01

'

'

'

'

'

'

'

'

'

'

Maximum percent of awards as a percent of total outstanding

'

'

'

'

'

'

'

'

'

10.00%

'

'

'

'

'

'

'

'

'

'

Cost not yet recognized

'

'

'

'

'

'

'

'

'

'

$1,700,000

'

'

$1,700,000

'

'

'

'

'

'

Equity-based compensation

'

0

0

'

'

'

'

'

'

'

600,000

'

13,000

700,000

31,000

'

'

'

'

'

Share based compensation related to vesting

'

'

'

'

'

'

'

'

'

'

'

'

'

100,000

'

'

'

'

'

'

Granted (in shares)

'

'

'

'

'

'

'

'

225,905

'

'

'

'

'

'

'

'

'

'

'

Shares issued in lieu of cash for services (in shares)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0

1,667

'

'

Value of shares issued in lieu of cash for services

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$15,000

'

'

EquityBased_Compensation_Restr

Equity-Based Compensation Restricted Stock Awards Activity (Details) (Unvested restricted stock, USD $)	9 Months Ended
	Sep. 30, 2014
Unvested restricted stock	'
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]	'
Beginning balance (in shares)	18,000
Granted (in shares)	225,905
Vested (in shares)	-18,000	[1]
Ending balance (in shares)	225,905
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]	'
Beginning balance (in dollars per share)	$9.23
Granted (in dollars per share)	$10.45
Vested (in dollars per share)	$9.23	[1]
Ending balance (in dollars per share)	$10.45
[1]	Previously granted unvested restricted stock outstanding vested as of the Listing.

EquityBased_Compensation_Multi

Equity-Based Compensation - Multi-Year Outperformance Plan Agreement (Details) (USD $)

3 Months Ended

9 Months Ended

0 Months Ended

3 Months Ended

9 Months Ended

0 Months Ended

3 Months Ended

9 Months Ended

In Thousands, except Share data, unless otherwise specified

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Apr. 07, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Apr. 07, 2014

Sep. 30, 2014

Sep. 30, 2014

OPP

OPP

OPP

OPP

OPP

OPP

OPP

OPP

OPP

OPP

OPP

OPP

OPP

OPP

OPP

OPP

OPP

OPP

OPP

OPP

OPP

OPP

OPP

OPP

OPP

OPP

Advisor

Significant Unobservable Inputs Level 3

Significant Unobservable Inputs Level 3

Performance Shares

Performance Shares

Performance Shares

Performance Shares

Performance Shares

Performance Shares

Performance Shares

Performance Shares

Performance Shares

Performance Shares

Performance Shares

Performance Shares

Performance Shares

Performance Shares

Performance Shares

Performance Shares

Performance Shares

Performance Shares

Performance Shares

Performance Shares

Performance Shares

Performance Shares

Performance Shares

Performance Shares

Performance Shares

Performance Shares

OPP

OPP

OPP

Cumulative Return, Above Threshold

Excess Return, Above Threshold

Excess Return, Above Peer Group

Cumulative Return, Equal to Threshold

Cumulative Return, Below Threshold

Performance Period

Performance Period

Performance Period

Performance Period

Annual Period

Annual Period

Annual Period

Annual Period

Interim Period

Interim Period

Interim Period

Interim Period

Minimum

Minimum

Minimum

Maximum

Maximum

Maximum

Performance Shares

Relative Component

Absolute Component

Relative Component

Relative Component

Relative Component

Excess Return, Above Threshold

100 Percent Cumulative Threshold

50% Component Threshold

0% Cumulative Threshold

Excess Return, Above Threshold

100 Percent Cumulative Threshold

50% Component Threshold

0% Cumulative Threshold

Excess Return, Above Threshold

100 Percent Cumulative Threshold

50% Component Threshold

0% Cumulative Threshold

Performance Period

Annual Period

Interim Period

Performance Period

Annual Period

Interim Period

Absolute Component

Relative Component

Relative Component

Relative Component

Absolute Component

Relative Component

Relative Component

Relative Component

Absolute Component

Relative Component

Relative Component

Relative Component

Cumulative Return, Above Threshold

Cumulative Return, Above Threshold

Cumulative Return, Above Threshold

Cumulative Return, Above Threshold

Cumulative Return, Above Threshold

Cumulative Return, Above Threshold

Relative Component

Relative Component

Relative Component

Relative Component

Relative Component

Relative Component

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Vested (in shares)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

9,219,108

'

'

Performance based award percentage

'

'

'

5.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Vesting percentage

'

'

'

'

'

33.33%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Return percentage threshold

'

'

'

'

'

'

'

'

'

'

'

21.00%

18.00%

0.00%

0.00%

7.00%

6.00%

0.00%

0.00%

14.00%

12.00%

0.00%

0.00%

0.00%

0.00%

0.00%

18.00%

6.00%

12.00%

'

'

'

Shares authorized

'

'

'

'

'

'

'

4.00%

4.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Shares awarded as a percentage of maximum

'

'

'

'

'

'

100.00%

'

'

50.00%

0.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Distribution entitlement percentage

'

'

'

'

'

10.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Dividends

'

$78,730

'

'

$300

$300

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Equity-based compensation

$0

'

$0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$200

$700

Net_Loss_Per_Share_Details

Net Loss Per Share (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, except Share data, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Earnings Per Share, Basic and Diluted, by Common Class, Including Two Class Method [Line Items]	'	'	'	'
Net loss attributable to stockholders (in thousands)	($12,121)	($5,475)	($116,445)	($12,339)
Basic and diluted weighted average shares outstanding (in shares)	169,090,342	178,231,121	175,234,437	142,163,876
Basic and diluted net loss per share attributable to stockholders (in dollars per share)	($0.07)	($0.03)	($0.66)	($0.09)
Common stock equivalents (in shares)	'	'	10,888,910	464,137
Unvested restricted stock	'	'	'	'
Earnings Per Share, Basic and Diluted, by Common Class, Including Two Class Method [Line Items]	'	'	'	'
Common stock equivalents (in shares)	'	'	225,905	22,200
OP units	'	'	'	'
Earnings Per Share, Basic and Diluted, by Common Class, Including Two Class Method [Line Items]	'	'	'	'
Common stock equivalents (in shares)	'	'	1,443,897	202
LTIP units	'	'	'	'
Earnings Per Share, Basic and Diluted, by Common Class, Including Two Class Method [Line Items]	'	'	'	'
Common stock equivalents (in shares)	'	'	9,219,108	0
Class B units	'	'	'	'
Earnings Per Share, Basic and Diluted, by Common Class, Including Two Class Method [Line Items]	'	'	'	'
Common stock equivalents (in shares)	'	'	0	441,735

NonControlling_Interests_Detai

Non-Controlling Interests (Details) (USD $)

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

12 Months Ended

3 Months Ended

9 Months Ended

0 Months Ended

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Dec. 31, 2013

Sep. 30, 2014

Mar. 31, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Dec. 31, 2013

Sep. 30, 2014

Sep. 30, 2014

Apr. 07, 2014

Apr. 07, 2014

Reliant Rehabilitation - Dallas, TX

Reliant Rehabilitation - Dallas, TX

Reliant Rehabilitation - Dallas, TX

Reliant Rehabilitation - Dallas, TX

Reliant Rehabilitation - Dallas, TX

Odessa Regional MOB - Odessa, TX

Odessa Regional MOB - Odessa, TX

Odessa Regional MOB - Odessa, TX

Odessa Regional MOB - Odessa, TX

Methodist North MOB - Peoria, IL

Methodist North MOB - Peoria, IL

Methodist North MOB - Peoria, IL

Methodist North MOB - Peoria, IL

University of Wisconsin Health MOB - Monona, WI

University of Wisconsin Health MOB - Monona, WI

University of Wisconsin Health MOB - Monona, WI

University of Wisconsin Health MOB - Monona, WI

Non-controlling Interests

Non-controlling Interests

Advisor

Advisor

Contract Purchase Price

Class B units

Advisor

Noncontrolling Interest [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Ownership interest units (in shares)

'

'

'

'

202

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Unearned class B unit (in shares)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,360,362

'

Limited partners' expected contributed capital

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$800,000

LLC or LP Member Units or Limited Partners, Expected Ownership Interest, (in shares)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

83,333

Operating partnership units held by related party (in shares)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,443,897

1,443,897

'

'

Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders

'

'

586,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

586,000

'

200,000

400,000

'

'

Net Investment Amount

0

'

0

'

'

0

[1]

'

'

0

[1]

'

0

[2]

'

0

[2]

'

0

[2]

'

0

[2]

'

0

[3]

'

0

[3]

'

'

'

'

'

'

'

Non-Controlling Ownership Percentage

'

'

'

'

'

0.00%

[1]

'

'

0.00%

[1]

'

0.00%

[2]

'

0.00%

[2]

'

0.00%

[2]

'

0.00%

[2]

'

0.00%

[3]

'

0.00%

[3]

'

'

'

'

'

'

'

Distributions

42,000

88,000

174,000

278,000

'

0

[1]

'

41,000

[1]

40,000

[1]

122,000

[1]

0

[2]

0

[2]

0

[2]

4,000

[2]

0

[2]

0

[2]

0

[2]

12,000

[2]

42,000

[3]

47,000

[3]

134,000

[3]

140,000

[3]

'

'

'

'

'

'

Payments to non-controlling interest holders

'

'

$4,300,000

'

'

'

$2,000,000

'

'

'

'

'

'

'

'

'

'

'

$2,300,000

'

'

'

$3,456,000

$100,000

'

'

'

'

[1]

During the three months ended March 31, 2014, Company fully redeemed the third parties' interest in Reliant Rehabilitation - Dallas, TX for an aggregate of $2.0 million.

[2]

During the year ended December 31, 2013, the Company fully redeemed the third parties' interest in Odessa Regional MOB - Odessa, TX and Methodist North MOB - Peoria, IL for an aggregate of $0.1 million.

[3]

During the three months ended September 30, 2014, the Company fully redeemed the third parties' interest in University of Wisconsin Health MOB - Monona, WI for an aggregate of $2.3 million.

Segment_Reporting_Details

Segment Reporting (Details) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
	segment	segment	segment	segment
Segment Reporting Information [Line Items]	'	'	'	'
Number of operating segments	3	3	3	3
Cash paid for income taxes	'	'	$1,590,000	$132,000
Rental income	63,311,000	29,285,000	166,412,000	66,157,000
Operating expense reimbursements	4,557,000	2,859,000	13,008,000	7,522,000
Resident services and fee income	5,741,000	2,003,000	14,947,000	3,083,000
Total revenues	73,609,000	34,147,000	194,367,000	76,762,000
Property operating and maintenance	31,315,000	13,940,000	81,032,000	26,576,000
Net operating income	42,294,000	20,207,000	113,335,000	50,186,000
Operating fees to affiliates	2,711,000	0	5,063,000	0
Acquisition and transaction related	10,266,000	3,107,000	36,144,000	7,858,000
Vesting of Class B units for asset management services	0	0	12,917,000	0
Fair value of listing note	-1,750,000	0	56,400,000	0
General and administrative	3,175,000	1,429,000	7,874,000	2,928,000
Equity-based compensation	'	0	'	0
Depreciation and amortization	32,606,000	17,140,000	93,262,000	41,548,000
Interest expense	7,942,000	4,350,000	20,593,000	10,754,000
Income from preferred equity investment and investment securities and interest income	-320,000	-354,000	-1,115,000	-609,000
Loss on sale of investment securities	464,000	'	129,000	'
Net loss (income) attributable to non-controlling interests	-679,000	10,000	-1,487,000	46,000
Net loss	-12,121,000	-5,475,000	-116,445,000	-12,339,000
Senior Living Facilities	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'
Cash paid for income taxes	400,000	'	1,000,000	400,000
Medical Office Buildings	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'
Rental income	20,844,000	13,026,000	61,564,000	34,053,000
Operating expense reimbursements	4,293,000	2,709,000	12,512,000	7,232,000
Resident services and fee income	0	0	0	0
Total revenues	25,137,000	15,735,000	74,076,000	41,285,000
Property operating and maintenance	5,093,000	3,312,000	14,781,000	8,577,000
Net operating income	20,044,000	12,423,000	59,295,000	32,708,000
Triple-Net Buildings	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'
Rental income	10,303,000	3,047,000	23,675,000	8,853,000
Operating expense reimbursements	264,000	150,000	496,000	290,000
Resident services and fee income	0	0	0	0
Total revenues	10,567,000	3,197,000	24,171,000	9,143,000
Property operating and maintenance	222,000	160,000	609,000	315,000
Net operating income	10,345,000	3,037,000	23,562,000	8,828,000
Seniors Housing Communities	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'
Rental income	32,164,000	13,212,000	81,173,000	23,251,000
Operating expense reimbursements	0	0	0	0
Resident services and fee income	5,741,000	2,003,000	14,947,000	3,083,000
Total revenues	37,905,000	15,215,000	96,120,000	26,334,000
Property operating and maintenance	26,000,000	10,468,000	65,642,000	17,684,000
Net operating income	$11,905,000	$4,747,000	$30,478,000	$8,650,000

Segment_Reporting_Segment_Acti

Segment Reporting - Segment Activity to Consolidated Total Assets (Details) (USD $)	Sep. 30, 2014	Dec. 31, 2013	Sep. 30, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Segment Reporting Information [Line Items]	'	'	'	'
Investments in real estate:	$2,055,108	$1,576,603	'	'
Cash and cash equivalents	33,452	103,447	308,911	13,869
Restricted cash	3,135	1,381	'	'
Investment securities, at fair value	1,587	14,670	'	'
Preferred equity investment	8,800	0	'	'
Prepaid expenses and other assets	27,725	17,431	'	'
Deferred costs, net	18,530	21,041	'	'
Total assets	2,148,337	1,734,573	'	'
Medical Office Buildings	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'
Investments in real estate:	974,669	948,122	'	'
Triple-Net Buildings	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'
Investments in real estate:	404,240	205,367	'	'
Seniors Housing Communities	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'
Investments in real estate:	$676,199	$423,114	'	'